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ABSTRACT 
ONE-CARBON METABOLISM RELATED B-VITAMINS 
ALTER 
THE EXPRESSION OF MICRORNAS AND TARGET GENES 
WITHIN THE WNT SIGNALING PATHWAY 
IN MOUSE COLONIC EPITHELIUM 
MAY 2016 
RICCARDO RACICOT, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Dr. Zhenhua Liu 
It has been widely recognized that microRNAs are involved in nearly all cellular processes that 
have been investigated and contribute to a variety of diseases including cancer. Our prior studies 
demonstrated the depletion of one-carbon metabolism related B-vitamins, including folate, 
vitamin B2, B6 and B12, induced a genomic DNA hypomethylation and an elevation of the 
tumorigenic Wnt signaling in mouse colonic epithelium. The present study aimed to define 
whether microRNAs serve as mediators between these B-vitamins and the Wnt signaling, and 
thereby influence intestinal tumorigenesis. MicroRNA expression profiles were measured using 
miRNA microarray and real-time PCR on colonic epithelial cells from Apc1638N mice fed with 
diets deplete or sufficient in those B-vitamins. In silico bioinformatic analysis were performed to 
predict microRNA gene targets within the Wnt signaling cascade. Out of 609 microRNA 
examined, 18 microRNAs were found to be either significantly (p < 0.05) or mildly (p < 0.10) 
differentially expressed in the colonic epithelium of mice fed the depleted diet when compared to 
the counterpart. Bioinformatic prediction of microRNA gene targets identified 40 genes within 
the Wnt pathway to have homology with microRNA seed sequences within their 3’-UTR or 
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protein coding sequence. Of the 6 genes tested for experimentally target validation, the 
expression of Sfrp1 was shown to be significantly inhibited (p < 0.05) whereas β-catenin was 
shown to be significantly elevated (p < 0.05) with alterations of others in a fashion indicating the 
activation of Wnt signaling.  These findings indicate that microRNAs may constitute a 
mechanism by which one-carbon B-vitamin depletions regulate the Wnt signaling pathway and 
thereby inform intestinal tumorigenesis. 
Key words: One-carbon metabolism, microRNA, Wnt pathway, Colorectal cancer 
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CHAPTER 1 
LITERATURE REVIEW 
1.1 microRNA 
microRNA (miRNA) are a class of short, non-coding RNA ~18-25 nucleotides in length 
which post-transcriptionally regulate mRNA expression in plants, animals and protozoa.  
Description of the C. elegans miRNA lin-4 in 1993 was the first characterization of a miRNA, 
offering the first insight into the regulatory role of non-coding RNA (Lee 1993). Regulatory 
function by miRNA was not described again until 2000 with the discovery of let-7, also in C. 
elegans (Reinhart 2000). Both miRNA were found to repress expression of various protein 
coding genes through imperfect complimentary basepairing with the 3’ UTR of mRNA (Reinhart 
2000).  These studies revealed key functions of miRNA, specifically temporal control of 
developmental events by miRNA through the regulation of interdependent genes (Reinhart 
2000). Since these findings, identification of miRNA has increased exponentially to over 28,000 
mature sequences registered in the miRBase database (www.miRBase.org, access on March 18, 
2016), of which 2,588 have been identified in humans and 1,915 in mice.  It is predicted that 
60% of all protein coding genes in the mammalian genome harbor target site in their 3’UTR for 
miRNA binding (Bushati 2007) (Sayed 2011). This ubiquitous nature indicates an important role 
for miRNA mediated regulation of cellular processes.  
1.1.1  microRNA biogenesis and function 
In the nucleus RNA polymerase II generates a primary stem-loop structure (pri-miRNA) 
varying in size from a few hundred nucleotides to kilobases in length (Bushati 2007). Once 
transcribed, pri-miRNA are processed in the nucleus by a protein complex known as the 
microprocessor. The microprocessor consists of the RNase III, DROSHA, and doublestranded 
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RNA binding domain (dsRBD) protein DGCR8 dimer. DROSHA recognizes and binds the 
ssRNA-dsRNA junction of pri-miRNA and uses this site as a molecular ruler to identify the 
cleavage site ~11 base pairs from the ssRNA-dsRNA junction. DGCR8 plays three distinct roles 
in pri-miRNA processing: binding and stabilization of the C-terminal tail, recruitment of the pri-
miRNA via the dsRBD and recognition of the apical UGU motif (Nguyen 2015). Once the pri-
miRNA is bound and oriented, DROSHA cleaves the pri-miRNA at the  cleavage site (Han 
2006), producing a ~70 bp hairpin loop structure known as the precursor-miRNA (pre-miRNA) 
with a 3’ 2 nucleotide overhang characteristic of RNase III mediated cleavage (Lee 2003). The 2 
nucleotide overhang is subsequently recognized by the transport molecule Exportin5, (Yi 2003) 
which shuttles the pre-miRNA to the cytoplasm for additional processing via a Ran-GTP 
dependent mechanism (Bohnsack 2004)  
In the cytoplasm, the RNase III Dicer anchors both the 3’ and 5’ end of the pre-miRNA 
and determines the cleavage site using the 5’ counting rule. Dicer identifies the 5’ phosphate cap 
and “measures” ~22 nucleotides from the 5’ terminal end of the pre-miRNA then cleaves both 
strands at this site, producing a small RNA duplex (Park 2011). The RNA duplex is actively 
loaded onto argonaute (AGO) and unwound. Duplex unwinding then typically occurs in an ATP-
independent manner. The current “rubber band” model suggests structural tension is applied in 
the open confirmation of AGO. Upon release tension is relieved, inducing duplex unwinding 
(Kawamata 2010). The strand not bound to AGO, termed the passenger strand, is then released 
and degraded (Matranga 2005).  
The remaining strand bound to AGO, termed the guide strand, has a complimentary 
sequence to its target mRNA and maintains a conformation preferential for target binding (Czech 
2009). The guide strand then directs the miRNA-induced silencing complex (miRISC), which is 
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comprised up of AGO and glycine-tryptophan repeat–containing protein (GW182), to gene 
targets (Bushati 2007). Upon engaging the target mRNA AGO will take an open conformation, 
exposing  bases 2-7 of the guide miRNA, termed the seed region, to face outward and allow for 
efficient recognition and base pairing to the target (Gan 2015).  
Depending on the degree of complementarity between the target and the guide, miRNA 
employ multiple mechanisms which result in the suppression of gene expression (Hutvagner 
2002) (Martinez 2004). If base pairing complementarity is near perfect, hydrolysis of the target is 
induced by AGO, leading to mRNA degradation by cellular exonucleases (Hutvagner 2002). 
Hydrolysis is mediated by only one isoform, AGO2 as it is the only catalytically active AGO in 
humans (Cheloufi 2010). Cleavage of phosphodiester bonds occurs between the target bases 
paired with bases 10 and 11 of the guide miRNA (Elbashir  2001). The two product fragments 
exposed to degradation by the SKI complex and 5’-3’ exoribonuclease 1 or 2 (XRN1, XRN2) 
(Chatterjee 2011).  
Non-cleavage translational repression of target genes only requires complementarity with 
the miRNA seed region (Filipowicz 2008). This allows miRNA to target and effectively suppress 
as many as 100-200 targets according to computational estimates (Krek 2005) (Lim 2005). 
Multiple in vitro models of translational repression have been proposed including cotranslational 
protein degradation (Nottrott 2006), inhibition of translation elongation (Gu 2009), ribosome 
drop-off leading to premature termination of translation (Petersen 2006), inhibition of translation 
initiation through interference of ribosome recruitment (Mathonnet 2007), sequestering of 
mRNAs in processing bodies (P bodies) void of ribosomes (Ding 2007), prevention of 
circularization (Zekri 2009), and deadenylation followed by decapping and subsequent 
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degradation (Chen 2009).  Despite the success of in vitro studies, it is unknown whether there is 
a primary mechanism or multiple mechanisms working in tandem   in vivo.  
1.1.2 microRNA in cancer development 
miRNA activity has been observed in nearly all cellular processes including 
development, metabolism, cell differentiation, proliferation and apoptosis. In accordance with 
their ubiquitous nature, miRNA activity has been linked 163 different diseases, and play a 
prominent role in colorectal cancerogenesis (Jiang 2009). In cancer, miRNA may act as either 
oncogenes by downregulating tumor suppressor genes or conversely act as tumor suppressors by 
downregulating oncogenes (Luo 2011).  
Differential miRNA expression in cancer cells and tissues versus adjacent normal tissue 
using microarrays is a method commonly used to establish cancer related miRNA profiles and 
has been utilized to create a miRNA expression profile in human CRC tissue (Schetter 2013). Of 
164 significantly altered miRNA in CRC, 2/3 demonstrate increased expression while the 
remaining 1/3 demonstrate decreased expression. This variance in expression indicates a favor 
towards oncogenic function of miRNA (Luo  2011).  Here we highlight the current literature 
demonstrating both tumor suppressive and oncogenic roles of miRNA in cancerogenesis with a 
focus on CRC when possible.  
1.1.2.1 Tumor Suppressor miRNA 
Increased expression of the miR-30 family has been shown to act as a tumor suppressor 
in humans. Tumor suppressive activity has been suggested by significant downregulation of 
miR-30 family miRNA, with concurrent increased expression of epithelial to mesenchymal 
(EMT) genes in human pancreatic islet cells (Joglekar 2009), prostate cells (Kao 2014) and 
hepatocytes (Budhu 2008) (Zhang 2012). A tumor suppressive role is attributed to targeting of 
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EMT genes such as vimentin and SNAIL which share the complementarity with the miR-30 seed 
sequence (Joglekar 2009). In addition, miR-30 has been shown to reduce stem-like features in 
tumor-initiating breast cells through targeting ubiquitin-conjugating enzyme 9 (Ubc9) and 
Integrin β3 (ITGB3) (Yu 2010).   
Tumor suppressive activity of miR-146a has been demonstrated in multiple cancer types 
including oral (Scapoli 2010), prostate (Lin 2008), breast (Bhaumik 2008), pancreatic (Li 2010), 
gastric (Kogo 2011) and colorectal (Mao 2014) cancers. CRC tissue (Mao 2014) and stool 
samples both exhibit downregulation of miR-146 (Ahmed 2013), suggesting a tumor suppressive 
role in the disease. miR-146  likely plays a role in suppression of metastasis as it targets 
SMAD4, a protein which is typically lost in CRC and is associated with EMT (Zhong 2010). 
Further, miR-146a expression levels have been shown to be decreased in metastatic tumor tissue 
when compared to primary tumor tissue (Pizzini 2013).  
To date, only one study has assessed the role of miR-361-5p in CRC. This initial data 
suggests a tumor suppressive role as expression was decreased in CRC when compared to 
normal tissue and overexpression inhibited invasion and metastasis (Ma 2015).Tumor 
suppressive action occurs through targeting of staphylococcal nuclease domain containing-1 
(SND1), which has been shown to have an oncogenic effect in CRC by downregulating APC 
(Tsuchida  2011). Interplay between miR-361-5p and SND1 acts as a feedback loop, as miR-
361-5p represses SND1 expression through binding of 3’-UTR while SND1 was found to bind to 
pre-miR-361-5p and negatively regulating its expression (Ma 2015).  
The role of miR-409-3p expression in cancer appears to be tissue specific. A tumor 
suppressive effect on lung adenocarcinoma (Wan 2014), bladder cancer (Xu 2013b) and CRC 
(Bai 2015) (Liu 2015)  has been demonstrated. However, miR-409-3p has an oncogenic effect in 
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prostate cancer (Josson 2014). Currently, only two studies have been performed in an attempt to 
elucidate the role of miR-409-3p in CRC (Bai 2015) (Liu 2015).  Neither study has provided a 
clear picture as to gene targets implicated in the tumor suppressive role of miR-409-3p in CRC. 
The serine/threonine kinase NLK has been verified by Liu et al as a target of miR-409-3p (Liu 
2015). Other studies have shown NLK is a mediator of  Wnt signaling through phosphorylation 
of TCF/LEF (Ishitani 1999). Bai et al have identified Grb2-associtated binder 1 (GAB1) as a 
target of miR-409-3p (Bai 2015). GAB1 is a scaffolding adapter protein which mediates cell 
growth and differentiation and has been implicated in tumor progression in CRC (Seiden-Long 
2008). Overexpression of miR-409-3p was shown to successfully downregulate GAB1 and 
suppress invasion both in vitro and in vivo (Bai 2015). 
The major product of stem-loop mir-139 is miR-139-5p and as such there are significant 
insights into its function, including downregulation and a tumor suppressive role in CRC (Shen 
2012). The minor product, miR-139-3p, has been studies less extensively. However, Liu et al 
have assessed the effect of miR-139-3p on CRC tissue from 63 patients with pathologically 
diagnosed primary colon cancer (Liu 2014a). miR-139-3p levels were found to be inversely 
associated with survival as patients with high expression of miR-139-3p had a significantly 
longer survival time compared with those with low expression (Liu 2014a). The results of this 
study are limited due to sample size and only assessed miR-139-3p as a diagnostic marker, 
providing no insight into its molecular role or targets (Liu 2014a). To date no gene targets for 
miR-139-3p have been validated in CRC tissue (Vlachos 2015).  
Downregulation of miR-125a-5p has been demonstrated in breast (Guo 2009) (O’Day 2010), 
ovarian (Nam 2008), lung (Wang 2009b), gastric (Nishida 2011), medulloblastoma (Ferretti  
2009) and colorectal cancer (Tong 2015) tissues. Recently Tong et al demonstrated 
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downregulation of miR-125a-5p in CRC tissues and cell lines and validated anti-apoptotic gene 
targets Bcl-2, BCL2L12 and MCL1 (Tong 2015). This study also showed an induction of 
apoptosis and inhibition of cell proliferation as a result of miR-125a-5p overexpression (Tong 
2015).   
1.1.2.2 Oncogenic miRNA 
miR-31-5p displays complex expression patterns in human cancers, exhibiting both 
oncogenic and tumor suppressive roles in disease development (Xu 2013a). In melanoma, breast 
and prostate cancer miR-31-5p is regularly down-regulated.  In contrast it is upregulated in lung, 
oral and colorectal cancers (Xu 2013a). Overexpression of miR-31-5p has been observed in CRC 
primary tumors isolated from all clinical stages of primary tumors as well as in cell lines 
(Bandrés 2006) (Wang 2009a) (Cekaite 2012) (Shee 2012) (Sun 2013) (Xu 2013a). High 
expression levels of miR-31-5p have been associated with advanced tumor stage and poor 
differentiation in CRC (Schee 2012). In addition, miR-31-5p expression levels have been shown 
to be elevated in premalignant polyps, indicating a role in early cancer development (Cekaite 
2012).  
Important targets for mir-31-5p in CRC development are the tumor suppressive GTPases 
RhoBTB1 and RASA1 (Xu 2013a) (Sun 2013) as well as TIAM1, a guanidine exchange factor 
of the Rac GTPase (Cottonham 2010). miR-31-5p is also associated with mutations in the  proto-
oncogenic gene BRAF in CRC tissue (Nosho 2014) (Ito 2014). BRAF mutations are linked to 
CpG island methylator phenotype (CIMP) which is defined as widespread CpG island promoter 
methylation, typically in DNA repair and tumor suppressor genes (Mojarad 2013) and has been 
correlated with increased expression of DNA methyltransferase 1 (Etoh 2004).  
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Oncogenic behavior of miR-27a-3p has been observed in multiple cancer types including 
breast (Guttilla 2009), gastric (Liu 2009) and kidney (Chow 2010). The relationship between 
miR-27a and CRC however has yet to be established. To date, one study has demonstrated tumor 
suppressive action in CRC (Bao 2014). The role of miR-27a in CRC is further complicated by 
the occurrence of two natural genetic variants of the miRNA (Wang 2014b). An A/G single 
nucleotide polymorphism (SNP) rs895819 in miR-27a appears to be associated with CRC 
susceptibility in ethnic Han Chinese (Cao 2014) (Wang 2014b). Wang et al was only able to 
show an association between the GG genotype (Wang 2014b) while Cao et al demonstrated an 
association between both the GG and AG genotypes and CRC (Cao 2014). Cao et al also 
observed increased relative expression of miR-27a in tumor tissues from those with the GG 
genotype and in those carrying at least one G allele when compared to tumors from AA patients, 
indicating an oncogenic role (Cao 2014). 
miR-92a and miR-92b belong to the miR-92 family  a member of the polycistronic mir-
17–92 cluster (Olive 2010). The mir-17-92 cluster was the first non-coding RNA to be described 
as an oncogene (He 2005) and consists of four miRNA families: the miR-17, miR-18, miR-19 
and miR-92 families (Olive 2010). He et al demonstrated overexpression of mir-17-92 in 
conjunction with overexpression of Myc, a known oncogene, increased the rate of development 
of malignant lymphomas when compared to overexpression of Myc alone (He 2005). However, 
overexpression of Myc along with individual miRNAs of the mir-17-92 cluster did not result in 
accelerated onset of disease (He 2005). The mir-17-92 cluster has also been implicated in 
hepatocellular carcinoma (Connolly 2008), medulloblastoma (Northcott 2009), leukemia (Li 
2012b), lung cancer (Hayashita 2005) and CRC (Nishida 2012).  
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Mature sequence miR-92a has been determined to be a key oncogenic component of the 
mir-17-92 cluster in the development of CRC (Tsuchida 2011). In both CRC adenomas and 
carcinomas mir-92a is transcribed at a higher rate than any other miRNA transcribed in the mir-
17-92 cluster and directly targets the pro-apoptotic tumor suppressor BCL-2-interacting mediator 
of cell death (BIM) (Tsuchidad 2011). Relative expression levels of miR-92a have been shown 
to be significantly elevated in CRC tissues when compared to normal adjacent mucosa (Zhou 
2013). Elevated expression of miR-92a has also been correlated with advanced clinical stage, 
lymph node metastases, distant metastases, while increased expression is an independent 
predictor of overall survival (Zhou 2013).  
To date miR-92b has been implicated in few malignancies; non-small cell lung cancer 
(Lei 2014), mantle cell lymphoma (Pal 2007) and Glioma (Li 2013). miR-92b levels are 
significantly elevated in high-grade gliomas compared with low-grade gliomas while 
overexpression has been shown to increase cell proliferation (Li 2013). Increased cell 
proliferation has been demonstrated to be regulated through modulation of the Wnt pathway, 
specifically by direct targeting and downregulation of the Wnt antagonist Dickkopf-3 (DKK3) (Li 
2013).  
Initially implicated in glioblastoma over a decade ago miR-21 is one of the earliest and 
most highly studied oncogenic miRNA (Chan 2005). Early evaluation of miRNA expression 
signatures in solid tumor tissues reported overexpression of miR-21 in all six tissue types 
considered; breast, CRC, lung, pancreas, prostate, stomach (Volinia 2006). Since these findings, 
overexpression of miR-21 has been reported in head and neck (Chang 2008), ovarian (Nam 
2008) and esophageal cancers (Mathé 2009), leukemia (Fulci 2007), lymphoma (Lawrie 2007), 
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multiple myeloma (Pichiorri 2008), osteosarcoma (Ziyan 2011), and spermatocytic seminoma 
(Gillis 2007).  
miR-21 expression levels have been established as a reliable prognostic marker (Kjaer-
Frifeldt 2012) (Zhang 2013) and a significant predictor of survival (Nielsen 2011) in patients 
with stage II CRC. miR-21 has multiple validated tumor suppressor gene targets in CRC 
including programmed cell death 4 (PDCD4) (Asangani 2008), transforming growth factor beta 
receptor 2 (TGFβR2) (Yu 2012), Cell division cycle 25A (Cdc25A) (Wang 2009c) Integrin-β4 
(ITGβ4) (Ferraro 2014) and, along with miR-31, TIAM1 (Cottonham 2010). Modulation of the 
Wnt pathway by miR-21 may play a role in CRC as Yu et al demonstrated a 60% reduction in 
Axin expression and increased expression of total β-catenin, c-Myc and cyclin-D1 in HCT-116 
cells overexpressing miR-21 (Yu 2012).  
 
1.2 Colorectal Cancer and the Wnt pathway  
1.2.1 Colorectal cancer incidence and mortality 
Traditionally, CRC is divided into three patterns: sporadic, familial or inherited cases. 75-
80% of CRC cases are considered sporadic, due to an apparent absence of familial history, while 
familial cases account for 20-25%, with the remaining 5-10% made up of inherited hereditary 
diseases (Amersi 2005). Significant familial history is defined: “if two or more first-degree 
relatives have been diagnosed with colon cancer or colon polyps at any age or if a first-degree 
relative has been diagnosed with colon cancer or colon polyps before the age of 60” (Amersi 
2005). Inherited cases of CRC are the result of either hereditary polyposis or nonpolyposis 
syndromes (Haggar 2009). 
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1.2.1.1 Incidence  
Worldwide, Colorectal Cancer (CRC) is the third most common cancer in both men and 
women, accounting for 10% of all cancer incidences (Stewart 2014). Since the 1980s, incidence 
of CRC in the United States has been rapidly declining likely due to improved screening 
methods leading to increased detection (Jemal 2011). This has led to an average decline in 
incidence of 3.4% per year between 2001 and 2010 in the US (Siegel 2014). Despite the 
improvement of incidence rates in the United States, as well as other Western countries, areas 
previously thought of as low-risk for CRC are showing drastic increases in incidence rates. 
Spain, Singapore and Israel have shown significant increases in recent years while Japan and the 
Czech Republic have now surpassed the peak incidence rates of the United States (Center 2010). 
This increased incidence is believed to be due to the spread of Western culture, defined as a lack 
of physical activity, increased intake of calorie-dense foods and increased prevalence of smoking 
(Center 2010).  
1.2.1.2 Mortality  
In the United States, CRC is the third most common cancer and the third leading cause of 
cancer death, resulting the death of an estimated 26,270 men and 24,040 women in 2014 (Siegel 
2014). However, mortality rates in the United States are decreasing at an increasing rate. 
Throughout the 1990s mortality decreased at an average rate of 2% per year, compared to an 
average of 3% between 2001 and 2010 (Howlander 2015). This decrease in mortality has been 
attributed to improved pattern changes in risk factors, treatment and screening (Edwards 2010). 
Improvements in screening have been vital to this decrease, accounting for 53% while changes in 
risk factor patterns and treatment account for 35% and 12%, respectively (Edwards 2010). As 
CRC progresses, five-year survival decreases. Diagnosis while the disease is in the localized 
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stage leads to a five-year survival of 90%. This rate decreases to 68% when the disease 
progresses to the regional stage and drastically decreases to 10% when distant metastasis occurs 
(Howlander 2015). This disparity in five-year survival demonstrates the importance of screening 
for early diagnosis, resulting in improved survival outcomes.  
1.2.1.3 Colorectal cancer and Wnt signaling  
Intestinal epithelium is the most rapidly self-renewing tissue in adult mammals with a 
turnover occurring every 5-7 days in the colon (Barker 2014). Regenerative capacity of the adult 
epithelium is regulated by Wnt signaling driven stem cell renewal (Barker 2014). Consequently, 
an important mechanistic role for Wnt signaling has been recognized in the development of CRC 
(Barker 2014). Over 90% of colon cancers possess activating mutations within the Wnt pathway 
(Fodde 2001). A variety of mutational and epigenetic silencing events within the Wnt pathway 
have been classified, most of which abrogate APC function (Moser 1993) (Jasperson 2014).  
1.2.2 The tumorigenic Wnt pathway 
The Wnt signaling pathway is an evolutionarily conserved pathway which regulates cell-
cell interactions in embryonic development, adult tissue regeneration, homeostasis and stem cell 
maintenance (Clevers 2006). The Wnt signaling pathway is a group of signal transduction 
pathways consisting of proteins that pass signals into a cell. The Wnt pathway is activated by 
binding a Wnt protein ligand to a Frizzled family receptor, which passes the biological signal to 
the protein dishevelled inside the cell (Nusse 1992). Wnt signaling is partitioned into 
subpathways: the canonical and noncanonical pathways. The canonical Wnt pathway is 
dependent on β-catenin, leading to regulation of gene transcription, whereas the noncanonical 
Wnt pathways are not dependent on β-catenin. There are two major noncanonical Wnt pathways: 
the planar cell polarity (PCP) pathway regulates the cytoskeleton that is responsible for the shape 
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of the cell and the noncanonical calcium pathway regulates calcium inside the cell (Rao 2010). 
The canonical Wnt signaling has been highly researched and plays significant role in cancer 
development (Clevers 2006) and will thus be the primary focus of this work.  
1.2.2.1 Wnt Ligands  
Individual discoveries in different species initially characterized Wnt genes as the 
segment polarity gene Wingless (wg) in Drosophila (Nusslein-Volhard 1980) and the mouse 
proto-oncogene integrated (Int-1) (Nusse 1982). Subsequent analysis determined Int-1 and wg to 
be homologous, forging an interrelation between oncogenic and developmental processes 
(Rijsewijk 1987).  
Wnt genes are expressed in all metazoan species and genomic analysis has revealed 19 
Wnt genes in human and mouse, 7 in Drosophila, and 5 in C. elegans (Nusse 2005). Human Wnt 
proteins are defined by gene sequence rather than function, sharing an average of 35% amino 
acid sequence identity and a conserved pattern of 23 or 24 cysteine residues (Logan 2004). All 
cysteine residues are believed to occupy intramolecular disulfide bridges providing the protein 
with a globular structure and characteristic hydrophobicity (Janda 2012).  
 
1.2.2.2 Wnt Antagonists  
Several secreted proteins bind Wnt in the extracellular matrix acting as antagonist for Wnt 
signaling (Cruciat 2012). Overall, small protein antagonists prevent ligand–receptor interactions 
or Wnt receptor maturation (Cruciat 2012). Two mechanisms for protein mediated inhibition 
seem to exist; binding to the Wnt co-receptor LRP6 and direct binding of, and sequestering Wnt 
proteins.  Dickkopf proteins (Dkks) (Glinka 1998), Wise/SOST (Semenov 2005) and insulin-like 
growth-factor binding protein 4 (IGFBP-4) (Zhu 2008) are the known proteins families which act 
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as Wnt antagonists through indirect inhibition. The inhibitors Secreted Frizzled-related proteins 
(sFRPs) (Leyns 1997), Wnt-inhibitory factor 1 (WIF-1) (Hsieh 1999) and klotho (Liu 2007b) 
function through direct binding of Wnt proteins.  
The Dkk family includes four proteins: Dkk1/2/3/4, with Dkk1, Dkk2 and Dkk4 playing 
a role in the regulation of Wnt signaling (Cruciat 2012). The mechanism of action for Dkk1/2 
involves high affinity binding to the Wnt coreceptor low-density lipoprotein receptor-related 
protein (LRP) 5/6 resulting in the inhibition of Wnt ligand binding (Niehrs 2001). The cystine 
knot–containing protein Wise/SOST has been proposed to act through similar mechanism as 
Dkk1/2, binding to the first two YWTD–EGF repeat domains of LRP5/6, modulating Wnt 
signaling in a cell context-dependent manner (Semenov 2005). IGFBP-4 abrogates Wnt signaling 
through direct binding of the conserved carboxy-terminal thyroglobulin domain to either of the 
Wnt coreceptors LRP6 or Frz8 (Zhu 2008).  
SFRP proteins represent the largest family of secreted Wnt inhibitors, comprising of five 
members: sFRP1/2/3/4/5 (Cruciat 2012). sFRP3 was first identified as Frzb (Frizzled motif 
associated with bone development), as it shares homology with the N-terminal cysteine rich 
domain of the transmembrane Wnt receptor Frizzled (Fzd) (Hoang 1996). Shortly after its 
identification, sFRP3 was found to be a an inhibitor of Wnt signaling (Leyns 1997). This initial 
work along with others demonstrated Wnt binding to sFRP3 resulting in sequester of Wnt 
proteins and subsequent abrogation of signaling (Leyns 1997) (Wang 1997). The conserved 
cysteine rich domain in the N-terminal motif of Fzd has been proposed as the Wnt ligand binding 
domain (Bhanot 1996) as it has been shown to be necessary and sufficient for sFRP-mediated 
inhibition of Wnt signaling (Lin 1997). An alternative mode of action for sFRP-mediated 
inhibition has also been proposed as sFRP and Fzd have been shown to dimerize via the cysteine 
15 
 
rich domain (Bafico 1999), a finding supported by crystal structures of the cysteine rich domains 
from mouse Fz8 and sFRP3 (Dann 2001).  
Overall, the mechanisms by which Wnt signaling is regulated in the extracellular 
environment have yet to be fully elucidated but appear to occur through a variety of mechanisms 
including the sequestering of Wnt proteins and binding of Wnt receptors. Further investigation of 
these agonists and antagonists will provide significant insights into the role of extracellular 
regulation of Wnt signaling. 
1.2.2.3 Post Transcriptional Modification 
 Post transcriptional modification, particularly acylation and glycosylation, has been 
shown to be essential for of Wnt protein function (Willert 2012). Glycosylation sites are variable 
in Wnt proteins in location and number (Ching 2008). Mutagenesis of glycosylated residues of 
Wnt3a (Komekado 2007) and Wnt5a (Kurayoshi 2007) limited their secretion, suggesting 
glycosylation likely plays a role in protein folding and secretion. However, this effect is not 
strongly observed in Wnt1 (Mason 1992). Glycosylation of Wnt is likely a precursor to acylation 
as it has been shown nonglycosylated Wnt3a is not acylated and therefore not secreted 
(Komekado 2007).  
1.2.2.4 Canonical Wnt Signaling 
In the absence of Wnt ligand binding to Fzd/LRP5/6, β-catenin is targeted for degradation 
(Li 2012a). In the cell, β-catenin is typically associated with the C-terminal tail of the 
transmembrane cell adhesion molecule E-cadherin (McCrea, 1995). Free cytoplasmic β-catenin 
is recognized and degraded by a muliprotein Axin destruction complex consisting of Axin, APC, 
GSK3β, Dvl, CK1α, βTrCP, and the proteasome (Li 2012a). Axin acts as the central scaffold of 
the destruction complex, directly interacting with all other core components (Liu 2002). Inside 
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the destruction complex, β-catenin is phosphorylated by the serine/threonine kinase casein kinase 
1α (CK1α) on S45 (Liu 2002). Phosphorylation of this residue is a primer necessary for 
subsequent phosphorylation of T41, S37 and S33 by glycogen synthase kinase 3β (GSK3β) (Liu 
2002). Phosphorylated β-catenin is recognized by the E3 ubiquitin ligase constituent F-box 
protein β-TrCP (Hart 1999) leading to ubiquitination (Aberle 1997). Upon ubiquitination β-
catenin is released from the Axin complex and degraded by the proteasome, allowing for reuse of 
the destruction complex (Li 2012a).  
Activation of Wnt signaling through Wnt ligand binding of Fzd/LRP5/6 results in the 
stabilization of cytoplasmic β-catenin and transduction of the Wnt signal (Clevers 2006). Binding 
of the Wnt ligand to LRP5/6 induces phosphorylation of five PPPSPxS motif (proline, serine or 
threonine, x, a variable residue) repeats by GSK3β (Zeng 2005) and CK1γ (Davidson 2005). 
Phosphorylation of the PPPSPxS motifs signals for sequestration of Axin (He 2004) which is 
recruited to LRP5/6 in the presence of a Wnt signal (Mao 2001). Sequestration of Axin to the 
membrane reduces the availability of cytoplasmic destruction complexes, resulting in β-catenin 
accumulation (Li 2012a). Upon stabilization and cytoplasmic accumulation, β-catenin 
translocates to the nucleus, activating TCF/LEF transcription factors (Molenaar 1996) (Behrens 
et al., 1996) and downstream Wnt target genes such as c-Myc (He 1998), cyclin-D1 (Tetsu 1999) 
and c-Jun (Mann 1999) 
1.2.3 Colorectal Cancer, One-Carbon Metabolism and Wnt signaling 
1.2.3.1 One-Carbon Metabolism 
One-carbon metabolism (OCM) is a set of reactions involving B vitamins riboflavin, B6, 
B12 and folate coenzymes (Ulrey 2005). One-carbon vitamins act as essential cofactors in 
nucleotide synthesis (Kim 2000) and the epigenetic process of biological methylation (Pufulete 
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2003). Epidemiologic observations as well as preclinical studies suggest that diminished folate 
status increases the risk of colorectal carcinogenesis (Giovannucci 2002) (Choi 2000). Folate 
plays an essential role in methylation by remethylation of homocysteine to methionine, the 
precursor of S-adenosylmethionine, the universal methyl donor for biological methylation 
(Selhub 2002). The reactions by which this occur are dependent on other one-carbon vitamins; 
riboflavin, B12 and B6 acting as cofactors (Ulrey 2005).  
One-carbon vitamins also assume critical roles as cofactors in the synthesis of 
nucleotides: riboflavin is a precursor for the cofactor of methylenetetrahydrofolate reductase, 
which catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate 
(Van den Veyver 2002); vitamin B12 is a cofactor for methionine synthase, a reaction in which 
5-methyltetrahydrofolate participates as a substrate in the remethylation of homocysteine to form 
methionine (van den Veyver 2002); and vitamin B6 is a necessary cofactor for the inter-
conversion of other coenzymatic forms of folate and the metabolism of homocysteine (Davis 
2004). Therefore metabolic functions of all these one-carbon vitamins are highly inter-
dependent, as depletion of one may lead to biochemical phenotypes characteristic of deficiencies 
of the others.  
1.2.3.2 One-Carbon Metabolism and Wnt Signaling 
Aberrant DNA methylation and DNA synthesis are among the most common molecular 
alterations that contribute to the development of human neoplasia (Jones 2002). Specifically in 
CRC, de novo methylation of the APC promoter region also plays an important role as a ‘‘second 
hit’’ in silencing APC expression in colorectal neoplasia (Arnold 2004). Our group has 
previously reported APC expression is also impaired by a severe degree of folate depletion: after 
5 weeks of depletion, strand breaks appeared in APC gene and these breaks were inversely 
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correlated to steady-state transcriptional levels of APC (Liu 2007a).We have further 
demonstrated mild depletion of one-carbon vitamins over 16 weeks increased both macroscopic 
tumor multiplicity and aberrant crypt foci by 50%, a 4-fold increase in Wnt signaling and 
changes in expression of Wnt signaling genes (Liu 2011). Thus, there is evidence that Wnt 
signaling could be altered by dietary inadequacy of one-carbon vitamins and play a role in 
colorectal tumorigenesis. 
 
1.3 microRNA and the Regulation of Wnt Signaling 
The role of miRNA in regulating Wnt signaling in specific cell and tissue types has yet to 
be firmly defined. Research has been non-contiguous and does not present a clear perspective. 
Anton et al have performed a systematic screen for miRNA regulating the canonical Wnt 
pathway in HEK293 cells and observed differential expression of 38 miRNA (Anton 2010). 
Other insights into the regulation of Wnt pathway genes by miRNA have been published which 
implicate a role in cancer (Nagel 2008) (Saydam 2009) (Gokhale 2010) (Haug 2011) (Kim 
2013).  
The effect of the miR-34 family expression on Wnt signaling has been studied in the most 
depth (Kim 2011) (Cha 2012) (Kim 2013). miR-34 has effectively married the tumor suppressor 
p53 and Wnt signaling pathway (Kim 2011) miR-34 is a transcriptional target of P53 and targets 
highly conserved sites in the UTR of Wnt genes;WNT3, LRP6, AXIN2, β-catenin, LEF1 (Kim 
2011). This results in suppression of TCF/LEF transcriptional activity, downregulating Wnt 
signaling related gene expression (Kim 2011). This effect has been demonstrated in breast, lung 
and colon cancer (Kim 2011). Specifically in CRC, expression of miR-34 suppresses Axin2 
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through binding at multiple 5′ and 3′ UTR sites, resulting in increased nuclear GSK-3β and 
decreased expression of the EMT regulator Snail (Kim 2013).  
Other miRNA that have shown tumor suppressive action through the regulation of Wnt 
signaling including miR-144 in bladder cancer (Guo 2013) and miR-200a in meningiomas 
(Saydam 2009). miR-144 has been demonstrated to have decreased expression in bladder cancer 
cell lines and tissues (Guo 2013).  This allows for expression of the gene target enhancer of zeste 
homolog 2 (EZH2), inactivating Wnt signaling and subsequent cell proliferation (Guo 2013). The 
miRNA expression profile brain cancer meningiomas shows downregulation of miR-200a 
(Saydam 2009). miR-200a directly targets and downregulates β-catenin mRNA and protein 
levels and downstream downregulation of cyclin D1 (Saydam 2009).  
Tumor suppressive actions of miRNA in Wnt signaling are not exclusive as two miRNA, 
miR-135a/b (Nagel 2008) and miR-92a/b (Haug 2011), have been shown to play an oncogenic 
role. Upregulation of miR-135a/b was found in colorectal adenomas and carcinomas resulting in 
downregulation of APC (Nagel 2008). miR-135a/b targets the 3′ UTR of APC, suppressing its 
expression and enhancing Wnt activity (Nagel 2008). Targeting and downregulation of APC by 
miR-135a/b was found to be successful regardless of the mutational status of APC (Nagel 2008). 
In neuroblastoma, miR-92a/b was found to downregulate the tumor suppressive Wnt antagonist 
DKK3 via binding target sites on the 3’ UTR (Haug 2011).  
 
1.4 Nutritional regulation of microRNA in Cancer Development 
Accumulating studies have reported regulation of miRNA expression by dietary factors. 
The focus of these studies has largely been the effect of essential nutrients and bioactive dietary 
compounds, such as those found in green tea, berries and turmeric in cancer development.  The 
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results of these studies demonstrate the ability of dietary components to regulate the expression 
of miRNA which target epigenetic mechanisms and play a role in downstream gene regulation.   
 
1.4.1 Essential Nutrients: Vitamin D and retinoic acid 
1.4.1.1 Vitamin D 
 The active metabolite of vitamin D, 1α,25-Dihydroxyvitamin D3 (1,25(OH)2D3) is a 
major cancer chemopreventive agent which acts through the induction of cell cycle arrest 
(Studzinski 1985). Exogenous 1,25(OH)2D3  has been studied for its effect on the mediation of 
miRNA expression in various cancer cell lines and has shown success in mediating  
cancerogenesis (Mohri 2009) (Giangreco 2013) (Wang 2009d) (Padi 2013) (Chang 2015) (Ma 
2014).  
Mohri et al have investigated the biological effects of 1,25(OH)2D3 binding to the vitamin 
D receptor (VDR) in cancer cell lines as previous data had shown gradual increase in VDR 
mRNA and protein expression levels  in parallel with ongoing dedifferentiation in the early 
phase of cancerogenesis, yet the VDR mRNA decreases to lower levels in late stage carcinomas 
(Cross 2001). These findings indicated post-transcription regulation of VDR (Mohri 2009). 
Indeed, this work identified a target sequence for miR-125b in the 3’-UTR of human VDR 
mRNA and verified targeting of this sequence using luciferase assay in ovarian granulosa-like 
tumor cell line KGN and breast cancer cell line MCF-7 (Mohri 2009). Treatment of MCF-7 cells 
with 1,25(OH)2D3 resulted in significant upregulation of VDR target genes which were markedly 
attenuated through overexpression of miR-125b (Mohri 2009). 1,25(OH)2D3 treatment 
demonstrated an antiproliferative effect in MCF-7 cells which was abrogated through 
overexpression of miR-125b  (Mohri 2009). This study confirmed posttranscriptional modulation 
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of VDR through miRNA targeting and demonstrates a diminutive role of miR-125b on the 
antiproliferative effect of 1,25(OH)2D3.  
miR-125b, along with miR-100 expression have also been shown to be modulated by 
1,25(OH)2D3  treatment in pancreatic cancer cells (Giangreco 2013). Expression levels of both 
miR-125b and miR-100 were markedly reduced in both tumor tissues and primary prostate 
cancer cells when compared to benign tissues and cells, respectively (Giangreco 2013). 
1,25(OH)2D3  treatment mediated upregulation of miR-125b and miR-100 and was VDR 
dependent (Giangreco 2013). Cancer invasiveness decreased with transfection of pre-miR-125b 
and pre-miR-100 in the absence of 1,25(OH)2D3 and was further reduced in 1,25(OH)2D3 treated 
cells (Giangreco 2013).  
In HL60 leukemia cells 1,25(OH)2D3 treatment has been shown to decrease the 
expression of miR-181a and miR-181b in a concentration and time-dependent manner (Wang 
2009d). 1,25(OH)2D3 treatment of HL60 cells induced G1 cell cycle arrest, downregulation of 
miR-181a and miR-181b and increased expression of tumor suppressive Cyclin-dependent 
kinase inhibitor 1B (p27Kip1), a cell cycle inhibitor (Wang 2009d). Transfection of pre-miR-181a 
abrogated of 1,25(OH)2D3 induced expression of p27
Kip1 and reduced G1 cell cycle arrest in 
HL60 cells (Wang 2009d). This suggests a role for miR-181 in cell cycle regulation which may 
be modulated by 1,25(OH)2D3.  
Evaluation of CRC cells have shown induction of miR-22 by 1,25(OH)2D3 treatment in a 
time-, dose- and VDR-dependent manner (Alvarez-Diaz 2012). Induction of miR-22 may be vital 
for the effectiveness of 1,25(OH)2D3, as miR-22 loss-of-function by transfection of a miR-22 
inhibitor (anti-miR-22) suppresses the antiproliferative effect and increased cell migration of 
HCT-116 and SW480-ADH cells (Alvarez-Diaz 2012). Further, transfection of anti-miR-22 
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resulted in increased expression of oncogenes NELL2, OGN, HNRPH1, RERE and NFAT5 
(Alvarez-Diaz 2012).  
miR-627 expression has also been shown to be upregulated in 1,25(OH)2D3
 treated CRC 
cells (Padi 2013). Treatment with 1,25(OH)2D3 resulted in increased cell doubling time by three 
hours (Padi 2013). To confirm miR-627 plays a role in 1,25(OH)2D3 mediated inhibition of cell 
proliferation, cells were transfected with miR-627, resulting in significantly inhibited growth of 
HCT-116 CRC cells (Padi 2013). JMJD1A, a histone demethylase which has been shown to 
promote CRC growth, was predicted and confirmed as a target of miR-627 as its overexpression 
results in downregulation of JMJD1A (Padi 2013).  
Significant alteration of miR-145 was also found in 1,25(OH)2D3 treated gastric cancer 
cells (Chang 2012). Decreased expression of miR-145 has been characterized in gastric cancer 
cells when compared to normal cells (Chang 2012). miR-145 expression was shown to be 
induced by 1,25(OH)2D3 treatment in a VDR dependent manner (Chang 2012). As with other 
1,25(OH)2D3 induced miRNA, overexpression of miR-145 led to induction of cell cycle arrest 
(Chang 2012). Two direct targets of miR-145 were identified and confirmed: E2F3 CDK6 
(Chang 2012). As with other cell types, one major effect of 1,25(OH)2D3 on gastric cancer cells 
is the modulation of cell cycle related genes through induction of miRNA.  
Differential expression analysis of miRNA in bladder cancer cells treated with 
1,25(OH)2D3 has yielded a novel miRNA expression profile (Ma 2015). Sixteen differentially 
expressed miRNA were identified including miR-10a, miR-22, miR-29a, miR-30d, miR-96, 
miR-125b-1, miR-126, miR-130a, miR-147, miR-147b, miR-193b, miR-335, miR-421, miR-
454, miR-542–5p, and miR-1237 (Ma 2015). Biological processes regulated by these miRNA 
were evaluated using the PANTHER pathway analysis program and found the top three 
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regulated biological processes to be: protein metabolism and modification (16%), protein 
phosphorylation (11%) and MAPKKK cascade (10%) in 253J cells, and stress response (21%), 
amino acid biosynthesis (15%) and sulfur metabolism (11%) in 253J-BV cells (Ma 2015). No 
analysis including gene target prediction or validation was performed.   
ii. Retinoic Acid 
The active vitamin A metabolite retinoic acid drives neurogenesis, cardiogenesis, body 
axis extension, development of the forelimb buds, foregut, and eye during embryonic 
development and is essential for vertebrate cell-cell signaling pathways that control 
differentiation including Wnt, TGF-β and hedgehog (Duester 2008). Modulation of miRNA 
expression by retinoic acid has been demonstrated in multiple cell types including leukemia 
(Garzon 2007), neural (Chen 2014) (Welch 2007) (Foley 2011) and breast cancer (Khan 2015). 
Treatment of patient derived leukemia cells with all-trans-retinoic acid (ATRA), a 
retinoic acid derivative, showed altered expression of nine miRNA, eight of which were 
upregulated (Garzon 2007). Of these eight up-regulated miRNA, let-7a-3 and let-7b transcription 
was shown to be activated via ATRA induced NFκB binding of the let-7a-3 promoter (Garzon 
2007). Further, ATRA treated cell exhibited downregulation of Bcl2 and RAS genes which was 
correlated to increased activation of known miRNA regulators of those proteins, let-7a and miR-
15a/miR-16-1, respectively (Garzon 2007). 
In ATRA treated U87 MG glioma cells, differential expression of 28 miRNA was 
demonstrated (Chen 2014). Of most significance was the near 10-fold upregulation of miR-302b, 
which was shown to target the transcriptional regulator of glioma proliferation E2F3 (Chen 
2014). Increased expression of miR-302b and subsequent repression of E2F3 expression was 
associated with apoptosis in a dose-dependent manner (Chen 2014). miRNA mediated E2F3 
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modulation by ATRA treatment has also been demonstrated in neuroblastoma cell lines (Welch 
2007). Typically repressed in neuroblastoma, ATRA treated cells demonstrated significant 
upregulation of miR-34a (Welch 2007). miR-34 was then shown to directly target E2F3, 
inducing the caspase-dependent apoptotic pathway (Welch 2007).  
Study of neuroblastoma cell lines treated with ATRA has also yielded insight into the 
tumor suppressive role of miR-10a and miR-10b (Foley 2011). ATRA treatment of SK-N-BE, 
LAN5 and SHSY-5Y cell lines led to overexpression of miR-10a/b and induced differentiation 
(Foley 2011). Ectopic overexpression of miR-10a/b similarly replicated the differentiated 
phenotype exhibited by the ATRA treated cells (Foley 2011). Direct targeting of nuclear receptor 
corepressor 2 (NCOR2), a corepressor of gene transcription which is known to suppress neurite 
outgrowth, by miR-10a/b resulted in neural cell differentiation and downstream repression of 
MYCN expression (Foley 2011).  
1.4.2 Essential nutrients: One-Carbon vitamins  
The mechanistic link between cancer susceptibility, one-carbon vitamins and epigenetics 
has been repeatedly shown to involve modulation of miRNA expression in the development of 
hepatocellular carcinoma (HCC) in rat liver (Kutay 2006) (Pogribny 2008) (Tryndyak 2009) 
(Starlard-Davenport 2010). This connection has also been shown in head and neck squamous cell 
carcinoma (Marsit 2006) and most recently CRC (Beckett 2015).    
Initial work by Kutay et al identified significant downregulation of miR-122a in rats fed a 
diet low in methionine (0.18%) and devoid of choline and folic acid when compared to controls 
fed the deficient diet supplemented with 0.58% L-methionine, 0.3% choline, and 2 mg/kg folic 
acid (Kutay 2006). Downregulation of miR-122a expression was confirmed in primary human 
HCC tissue samples (Kutay 2006). Follow up study identified downregulation of tumor 
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suppressor miRNAs miR-34a, miR-16, and miR-127 (Pogribny 2008). In rats fed a methyl 
deficient diet, western blot analysis revealed increased protein levels of respective gene targets 
miR-34a and miR-127; E2F3 and BCL6 (Pogribny 2008). Further analysis by this group 
reaffirmed downregulation of miR-34a and miR-127 in the developmental stages of HCC in rats 
fed a methyl deficient diet in addition to showing aberrant expression of miR-200b and miR-16a 
(Tyndyak 2008). Corresponding upregulation of gene targets E2F3, NOTCH1, Bcl-6, and Bcl-2 
proteins were confirmed and related to dysregulated apoptosis as well as upregulation of  
ZFHX1B, a known inducer of EMT (Tyndyak 2008). miR-155 and miR-221 were found to be 
upregulated in liver cells of mice fed methyl deficient diets in a subsequent study, however no 
gene targets were verified (Starland-Davenport 2010).  
In a cultured cell study of lymphoblast cell line TK-6, aberrant miRNA expression 
profiles in cells grown in a methyl deficient medium was found (Marsit 2006). This effect 
imparted by a methyl deficient diet was reversible when adding a complete medium (Marsit 
2006). Of note was significant overexpression of miR-222 in methyl deficient cells (Marsit 
2006). This finding confirmed in vivo using human peripheral blood from individuals with head 
and neck squamous cell carcinoma and low folate intake which showed subjects at the bottom 
one percentile of dietary folate intake had significantly higher expression of miR-222 when 
compared to subjects at the top one percentile (Marsit 2006).  
To date, analysis of the effect of methyl deficient diets on miRNA in human CRC have 
only been evaluated in a single study. Serum miR-21, folate and B12 were evaluated in a primary 
case–control cohort consisting of patients with colonoscopy confirmed adenomatous colon 
polyps as well as in a secondary cohort taken from a large cross-sectional cohort of 649 elderly 
participants who gave blood (Beckett 2015). Folate and B12 were measured by chemiluminescent 
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assay while miR-21 expression was quantified using qPCR (Beckett 2015). In the primary cohort 
significant upregulation of plasma miR-21 was found in women with adenomatous polyps and 
cases had significantly higher erythrocyte bound folate than controls, but not in men (Beckett 
2015). miR-21 expression varied significantly with folate levels in both females  and males in 
both cohorts (Beckett 2015). This finding was supported using a cultured cell models showing 
increased expression of miR-21 in cells treated with excess folate, even when results were 
corrected for proliferation (Beckett 2015).  
Previous work by our group has demonstrated combined mild depletion of one-carbon 
vitamins (Liu 2007a) (Liu 2011) affects colorectal carcinogenesis. Mice fed a one-carbon 
vitamin depleted diet were found to have strand breaks in the APC gene (Liu 2007a), increased 
Wnt signaling, increased tumor multiplicity, increased tumor incidence and increased aberrant 
crypt foci  in vivo (Liu 2011). These studies effectively demonstrate a Wnt signaling mediated 
role in the development of CRC associated with dietary one-carbon vitamin intake and provide 
the basis for our current work.  
1.4.3 Bioactive compounds 
1.4.3.1 Epigallocatechin Gallate (EGCG) 
 The green tea polyphenol Epigallocatechin gallate (EGCG) has been shown to suppress 
proliferation, invasiveness and tumor growth (Fang 2015). Microarray analysis of 328 miRNA 
from EGCG treated HepG2 human hepatocellular carcinoma cells revealed aberrant expression 
compared to control cells (Tsang 2010). Downregulation of 48 miRNA including oncogenic 
miR-21 and upregulation of 13 miRNA including tumor suppressive miR-16 was found (Tsang 
2010). Downregulation of miR-21 has also been found in EGCG treated mouse prostate tumor 
tissues along with upregulation of tumor suppressive miR-330 (Siddiqui 2011).  
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1.4.3.2 Resveratrol 
 Resveratrol (trans-3,4′,5-trihydroxystilbene), a dietary polyphenolic compound found in 
plant sources such as grapes and berries has demonstrated promise for cancer treatment and 
prevention in preclinical trials (Bishayee 2009). Mediation of miRNA expression by resveratrol 
has been shown in several cancer cell lines (Tili 2010). Resveratrol treatment of human leukemia 
cells resulted in upregulation of tumor suppressor miR-663, decreasing activity of target 
activator protein-1 (AP-1) factors JunB and JunD and lipopolysaccharide endotoxins, leading to 
impaired lipopolysaccharide induced upregulation of oncogenic miR-155 (Tili 2010).  
Assessment of miRNA expression profiles from SW480 CRC cells treated with 
resveratrol showed downregulation of 26 miRNA, including CRC-associated oncogenic miR-21 
and miR-92a, and upregulation of 22 miRNA, including miR-663 (Tili 2010). Resveratrol 
mediated suppression of oncogenic miRNA expression was correlated with increased protein 
levels of their gene targets including Dicer1 and tumor suppressor factors PDCD4 and PTEN 
(Tili 2010). Increase in miR-663 expression was associated with downregulation of key effectors 
of the TGF-β pathway which is involved in cell proliferation, differentiation, migration and 
apoptosis (Tili 2010).  
1.4.3.2 Curcumin 
 Curcumin is the main bioactive compound in the spice turmeric and has been 
demonstrate to have a prolific anti-cancer effect in recent years (Anand 2008) . A number of 
studies show this effect may be related to altered miRNA expression induced by curcumin 
treatment (Sun 2008) (Yang 2010) (Zhang 2010) (Saini 2011) (Gao 2012) (Dahmke 2013) 
(Kronski 2014) (Guo 2015). All studies to date indicate curcumin induces upregulation of tumor 
suppressor miRNA leading to subsequent downregulation of oncogenic targets (Sun 2008) (Yang 
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2010) (Zhang 2010) (Saini 2011) (Gao 2012) (Dahmke 2013) (Kronski 2014) with some effect 
exhibited on the downregulation of oncogenic miRNA (Sun 2008) (Zhang 2010) (Guo 2015).  
In the initial study demonstrating this effect, Sun et al showed significant upregulation of 
the miR-22 and downregulation of miR-199a-3p in xBC-3 human pancreatic cancer cells (Sun 
2008). Upregulation of miR-22 was associated with suppressed expression of P1 transcription 
factor (SP1) a gene associated with tumor growth and metastases and estrogen receptor 1 
(ESR1), an important breast cancer target with a role in cellular responsiveness to estrogens and 
antiestrogens (Sun 2008). 
In breast cancer cells, curcumin related modulation of the prometatstatic and 
proinflammatory cytokines CXCL1 and -2 has been shown to be controlled by upregulation of 
miR-181b in MDA-MB-231 cell lines (Kronski 2014). Mediation of the anti-apoptotic factor 
Bcl-2 by curcumin induced upregulation of miR-15a and miR-16 has been shown in cell lines 
MCF-7, SKBR-2 and Bcap-37 when compared to controls (Yang 2010). This pair of miRNA, 
miR-15a and miR-16, have also been shown to be upregulated in curcumin treated K562 and 
HL-60 leukemia cells and regulate the expression of Wilms' tumor 1 (WT1) an oncogenic 
transcription factor commonly upregulated in acute human leukemia and chronic myelogeous 
leukemia (Gao 2012).    
In addition, targeting of Bcl-2 via curcumin induced modulation of miRNA has been 
shown to be exhibited in murine melanoma (Dahmke 2013). A diet consisting of 4% curcumin 
was fed to C57BL/6 mice injected with murine B78H1 melanoma cells, leading to a 100-fold 
increase in expression of miR-205-5p and a significant decrease in predicted targets Bcl-2 and 
proliferating cell nuclear antigen (PCNA) (Dahmke 2013).  
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In bladder cancer, miR-203 is frequently downregulated due to MIR203 promoter 
hypermethylation (Saini 2011). Saini et al demonstrated curcumin mediated restoration of miR-
203 in bladder cancer cell lines, leading to inhibited proliferation, migration, invasion and 
induced cell-cycle arrest, and apoptosis  through targeting of the oncogenes Akt2, Src, c-jun and 
survivin (Saini 2011). Interestingly, restoration of miR-203 function is believed to be mediated 
through epigenetic modulation via hypomethylation of the miR-203 promoter as curcumin 
inhibits DNMT1 and induces global genomic DNA hypomethylation (Saini 2013).  
Downregulation of oncogenic miRNA by curcumin treatment has been demonstrated in 
pancreatic (Sun 2008), andenocarcinoma (Zhang 2010) and prostate cancer cells (Guo 2015). In 
the multidrug-resistant human lung adenocarcinoma cell line A549/DDP, curcumin treatment 
was shown to induce cell proliferation and induce apoptosis (Zhang 2010). Further investigation 
revealed this effect to be likely due to decreased expression of miR-186-3p, however no target 
genes associated with this effect were established (Zhang 2010).  
Most recently, the effects of curcumin on miRNA expression in prostate cancer cells has 
been studied. Guo et al demonstrated curcumin treatment of PC3 cells led to downregulation of 
miR-208 in a dose-dependent manner (Guo 2015).  Downregulation of miR-208 led to increased 
expression of its target CDKN1A, a cell cycle regulator, resulting in decreased cell proliferation 
(Guo 2015).   
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CHAPTER 2 
PURPOSE OF THE STUDY 
2.1 Overview 
In the United States, Colorectal Cancer (CRC) is the third most common cancer and the 
third leading cause of cancer death, resulting in the death of an estimated 26,270 men and 24,040 
women in 2014 (Siegel 2014). Convincing evidence indicates Western lifestyle and diet are 
critical factors for the development of CRC. Observational studies show physical inactivity, 
obesity, alcohol consumption and smoking coupled with low intakes of fruits, vegetables and 
whole grains, as well as high intake of red and processed meats are associated with increased risk 
of this cancer (Durko 2014). However, a significant scientific gap exists in understanding the 
mechanism(s) mediating this epidemiological phenomenon. Therefore, to elucidate the cellular 
pathways by which environmental factors, including the critical dietary factor, mediate the 
development of CRC is of vital importance to combat this prevalent disease.  
CRC tumorigenesis is a multistep process that results from accumulations of a complex 
series of genetic and epigenetic abnormalities under aberrant microenvironmental influence. A 
vast majority (>90%) of colon cancers in humans possess over-activation of the tumorigenic Wnt 
signaling pathway and there is strong evidence that this activation is pivotal in CRC 
carcinogenesis (Fodde 2001).  CRC is traditionally divided into sporadic (75-80%) and familial 
(hereditary) cases (20 ~25%) (de la Chapelle, 2004). Among familial CRC, only ~5% are due 
directly to inherited genetic mutations. Approximate 20% have a positive family history but 
cannot be categorized into hereditary CRC syndrome (Al-Sohaily 2011) (Power 2010). Familial 
Adenomatous Polyposis (FAP), a hereditary CRC with mutations in the APC gene within the 
Wnt pathway (Kinzler, 1996), only account for a small portion (1~2% of all CRCs) (Fodde 
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2001). Therefore, the large portion of aberrant Wnt signaling as described above are not due to 
inherited origins and might be induced by environmental factors including diet (Narayan 2003).  
The Wnt pathway is a cell signaling pathway mediated by the highly conserved Wnt 
family of secretory glycoproteins. Wnt proteins signal cell proliferation (van de Wetering 2002), 
polarity (Wong 1993) and fate (Miller 1996) during embryogenesis as well as regulate adult 
tissue homeostasis (Reya 2003). In the canonical pathway, a Wnt ligand binds to the membrane-
bound frizzled (Fzd) receptor and a co-receptor, low density lipoprotein receptor-related protein 
6 (LRP6), allowing for transduction of the Wnt signaling pathway (Wodarz 1998).  Binding of 
the Wnt ligand to Fzd and Lrp6 recruits Axin to the cell membrane, resulting in the sequester of 
the Axin/Apc/GSK3β destruction complex, thereby hindering β-catenin degradation and 
allowing its stabilization (Clevers 2006). The β-catenin protein then translocates into the nucleus 
where it associates with T cell factor/lymphoid enhancer (TCF/LEF) transcription factors 
(Molenaar 1996) (Behrens 1996) activating transcription of downstream Wnt target oncogenes 
such as c-Myc (He 1998), cyclin-D1 (Tetsu 1999) and c-Jun (Mann 1999).   
The association between folate and CRC has been well demonstrated in epidemiological 
and preclinical studies (Giovannucci, 2002) (Choi 2000) (Kim 2005). Folate is required as a 
methyl donor to homocysteine for the synthesis of methionine, which derives the universal 
methyl donor (S-adenosylmethionine) for DNA methylation  (van den Veyver, 2002). Within this 
process, other B-vitamins, such as vitamin B2, B6 and B12, also participate in the reactions as 
co-factors.   Deficiency in these nutrients has also been shown to result in hypomethylation in the 
colon (Liu 2007). It is also demonstrated that, compared to healthy colonic epithelium, CRC 
cells typically exhibit genomic hypomethylation, and conversely gene-specific promoter 
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hypermethylation, which may act in transcriptional silencing of gene expression and thereby lead 
to CRC (Fearon 2010).  
In the recent decade, miRNAs are of particular interest in cancer research as expression 
modification by miRNAs has been implicated in CRC by targeting mRNAs that encoding either 
oncogenes or tumor suppressors (Slaby 2009). miRNAs may stimulate cancer proliferation by 
affecting biological reactions related the development of cancer, such as cell proliferation, 
evasion of growth suppression and resistance to cell death (Ross 2011). miRNAs can regulate 
gene expression, but by themselves can also be regulated by epigenetic modification. miRNAs 
can be regulated through promotor methylation as well as histone modifications (Liu 2014). CpG 
island promoter hypermethylation in a number of miRNAs has been demonstrated to be a 
hallmark of metastasis in human cancer (Lujambio 2008).  
2.2 Hypothesis and Specific Aims  
A prior studies from our laboratory have demonstrated the depletion of one-carbon 
metabolism related B-vitamins including folate, vitamin B2, B6 and B12, so-called ‘one-carbon 
vitamins’, induced a genomic DNA hypomethylation in mouse colonic epithelium, and 
alterations on multiple components within the Wnt signaling pathway were identified (Liu 2007). 
Extending from these observations, another study using Apc1638N intestinal cancer model coupled 
with a “Wnt-reporter” mouse model (BAT-LacZ) further demonstrated that combined 
inadequacies of one-carbon vitamins amplified colonic Wnt signaling indicated by elevation of 
the externally inserted and β-catenin-dependent “Wnt-reporter” gene, β-galactosidase. This 
reporter gene provides genuine indication of the activation of Wnt pathway.  This study also 
demonstrated increased intestinal tumor incidence and multiplicity consequent to the 
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inadequacies of these B-vitamins and the elevated Wnt signaling (Liu 2011).  Although Strand 
breaks in the mutation cluster region of the APC gene was indicated as a possible target by one-
carbon vitamin depletions, it does not exclude other potential mechanisms and pathways which 
may also be mediated the one-carbon metabolisms given their critical roles in both biological 
methylation as well as nucleotide synthesis (Liu 2007) (Liu 2011). Strikingly, recent studies 
indicate that miRNAs not only possess a role in the regulation of Wnt signaling pathway (Anton 
2011), but also target the one-carbon metabolism pathway (Stone 2011). Therefore, we 
hypothesize in the present study that combined inadequacies of one-carbon vitamins mediates 
the Wnt signaling pathway via controlling the expression of miRNAs. To test this hypothesis, we 
utilized colonic epithelial samples from mice fed either a one-carbon vitamin deficient diet 
(folate, riboflavin, B6 and B12 depletion) or their replete diet, and pursue the following two 
specific aims:  
Specific Aim #1: Using miRNA array to identify what miRNAs are altered by one-
carbon vitamin depletion. 
Specific Aim #2: In silico prediction of miRNA target genes within the Wnt signaling 
cascade, and experimental validation of the predicted Wnt pathway-specific genes.  
2.3 Significance 
 In this work we define relationships between dietary intake of one-carbon vitamins, 
miRNAs, Wnt signaling and colorectal cancer. This provides a new lens to understand the 
parthenogenesis of the disease in relation to dietary B-vitamin status.  We discover a miRNA 
expression profile for colorectal epithelial tissue with one-carbon vitamin depletion. This 
research is the first to elucidate the effect of one-carbon vitamin deficiencies on miRNA 
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expression and presents the identification of their Wnt signaling-specific gene targets in 
colorectal epithelium. An understanding of the molecular and biochemical responses produced 
by one-carbon vitamin should be beneficiary to the public health via designing appropriate 
dietary strategies.   
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CHAPTER 3 
EXPERIMENTAL DESIGN AND METHODS 
Colonic samples used in this project were collected from an animal study performed in 
Tufts University. The protocol was approved by the Institutional Animal Care and Use 
Committee at the Jean Mayer U.S. Department of Agriculture (USDA) Human Nutrition 
Research Center on Aging at Tufts University. Brief descriptions for the animals, diets, as well 
as sample collections were shown below, more details regarding the experimental design can be 
found in our previous publication (Liu 2011). 
3.1 Animals and Sample Preparation 
3.1.1 Animals and Diets 
The tumorigenic model, Apc1638N, was intentionally selected to investigate the 
modulation of intestinal tumorigenesis. This model possesses a mild tumorigenic phenotype 
(Pretlow 2003), which is particularly useful for this type of experiment, since the very aggressive 
tumorigenic phenotypes present in many of the more commonly used models, such as the Apcmin 
mouse, readily overwhelm the modest effects produced by nutritional interventions. Both strains, 
which are on the C57BL/6 background, were bred and cross-bred in our center. These animals 
were pair-fed one of two experimental diets that contained different levels of folate and vitamin 
B2, B6, and B12 (Table 1) for 16 wk beginning at 8 wk of age. The amino acid-defined diet was 
originally designed to precisely govern folate status (Clifford 1989) and has been used 
extensively in our previous studies (Song 2000). It is noteworthy that diets intended to induce 
very mild degrees of dietary vitamin depletion were used in this study; this issue is discussed in 
greater depth in our previous publication (Liu 2011). 
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3.1.2 Colonocyte Isolation and Sample Preparation 
 After consuming the experimental diets for 16 weeks (from the age of 8 weeks to 24 
weeks), all mice were anesthetized and then exsanguinated by cardiac puncture. The method for 
colonocyte isolation was previously described (Bjerknes 1981) and with slight modification. 
After washing with ice-cold PBS, the colon was inverted and incubated in 30 mM EDTA at 4°C 
for 30 mins. The colonocyte was then scraped off gently with forceps. The muscular and 
connecting tissue were discarded and the isolated colonocytes were washed with PBS. After 
centrifugation, the isolated colonocyte pellets collected into 1.5 ml Eppendorf tube and frozen in 
-80°C for the following DNA or RNA extraction and molecular assays. 
Table 1 Concentrations of one-carbon vitamins in the experimental diet. 
Treatment 
Riboflavin 
(mg/kg) 
Pyridoxine HCl 
(mg/kg) 
B12 (µg/kg) 
Folic acid 
(mg/kg) 
Folate sufficiency 
(control) 
6.0 7.0 5.0 2.0 
Multiple vitamin 
depletion (MVD) 
0.5 0.5 0.0 0.0 
 
3.2 The measurement of microRNA profile 
3.2.1 Affymetrix microRNA array 
miRNA expression profile analysis were performed on isolated colonic epithelial cells 
from 6 Apc1638N mice fed control or MVD diets using the Affymetrix GeneChip miRNA Array v. 
1.0. The GeneChip miRNA Array v. 1.0 covers 71 organisms including mouse, rat, human, 
monkey, canine and others. A total of 609 mouse miRNAs were included in this Genechip.   
Total RNA and miRNA extraction from tissue samples were performed using using TRIzol® 
(Invitrogen, ThermoFisher Scientific). miRNA were labeled using the FlashTag Biotin HSR 
labeling kit according to manufacturer’s protocol (Affymetrix, CA). First, Poly (A) tailing is 
performed at 37°C for 15 minutes, subsequently followed by ligation of the FlashTag biotin 
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signaling molecule, performed at room temperature for 30 minutes, before the addition of the 
Stop Solution. The labeled RNA samples were then added to a hybridization mixture and 
hybridized on the microarray overnight. Following hybridization, the arrays were washed and 
stained using the Affymetrix Fluidics Station 450 and scanned with the Affymetrix GeneChip 
Scanner 3000 7G using the Command Console software. Affymetrix miRNA QCTool were used 
for quality control, with following-up statistical analysis using SAS v9.4 as described in the 
statistical section. 
3.2.2 Validation of microRNA array by real-time PCR. 
To validate the results of Affymetrix miRNA array, we selected two miRNAs (miR21, 
and miR122) whose expressions were identified by the miRNA microarray to be significantly 
changed between the control and one-carbon vitamin depletion group. We also selected 3 
miRNAs within the miR-29 family (miR-29a, miR-29b and miR-29c) whose expression were 
detected in the Affymetrix miRNA array, but the differences between the one-carbon vitamin 
depletion group and replete control group did not reach a statistically significant degree. These 
three miRNAs were associated with colorectal cancer (Kapinas 2010). Moreover, the family of 
miR-34, consisting of miR-34a, b and c, is known to regulate the processes of growth, apoptosis 
and metastasis (Roy 2012). However, the signals for this miR-34 family were below the 
detectable level in the Affymetrix microarray, we examined their expressions by real-time PCR. 
For the examination of these miRNAs, the production of cDNA by reverse transcription were 
performed using NCodeTM miRNA First-Strand cDNA Synthesis kit (Invitrogen, ThermoFisher 
Scientific). All the miRNAs in the RNA sample (2 ug) were polyadenlyated using poly A 
polymerase and ATP. Following polyadenylation, SuperScript III reverse transferase and a 
specially-designed universal RT primer were used to synthesize cDNA from the tailed miRNA 
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population.  Real-time PCR analysis was performed on ABI prism 7300 (Applied Biosystems) 
using the SYBR Green master mix (Applied Biosystems, ThermoFisher Scientific). miRNA 
detection was performed using SYBR Green. Data was normalized using the average Ct value of 
two mouse housekeeper genes, sno-251 and sno-55 for miR-21, 122, 29a, 29b and 29c, whereas 
the Ct value of 5s rRNA were used as control for the normalization of miR34a, 34b and 34c. The 
selections of housekeeping small RNAs as controls for the normalization did not make 
significant differences. The miRNA and forward primer sequences were shown on 
Supplementary Table 1.   
3.3 Prediction of microRNA target genes within the Wnt pathway 
3.3.1 The prediction of miRNA targets by DIANA mirPath 
Gene target predictions for 18 miRNAs with either significant (p<0.05) or mildly altered 
expression (p<0.10) identified by Affymetrix array or Real-Time PCR was performed using the 
DNA Intelligent Analysis (DIANA) miRNA pathway analysis webserver DIANA-miRPath v2.0. 
This target prediction tool provides the highest sensitivity and specificity when compared to 
other available miRNA target prediction tools, although this produces fewer results (Reczko 
2012a). In silico miRNA target prediction is performed using the latest version of DIANA-
microT algorithm, DIANA-microT-CDS, an algorithm which computes a miRNA–gene 
interaction score for predicted targets and/or experimentally verified targets derived from 
DIANA-TarBase v6.0. DIANA-miRPath v2.0 allows for hierarchal clustering based on 
interaction levels as well as pathway enrichment utilizing Kyoto Encyclopedia of Genes and 
Genomes (KEGG) v58.1 for Mus musculus (Vlachos 2012).  
DIANA-microT-CDS predicted targets were utilized as few targets have been verified 
and thus using DIANA-TarBase v6.0 yielded few results. DIANA-microT-CDS has been 
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updated to utilize miRBase version 18 and Ensembl version 69 target sequences from both 3′-
UTR and protein coding sequence (CDS) transcripts while other miRNA-gene interaction 
algorithms use 3′-UTR target sites alone (Reczko 2012b). This allows for increased sensitivity as 
miRNA favor target sites in the CDS in genes with short 3′-UTRs (Reczko 2012b).  DIANA-
microT-CDS has been demonstrated to have the highest sensitivity at any level of specificity 
when compared with other state-of-the-art miRNA-gene interaction algorithms when tested 
against pulsed stable isotope labeling by amino acids in cell culture (pSILAC) proteomics data 
sets (Reczko 2012a). An interaction score cut-off of 0.8 was chosen as it provides a manageable 
number of predicted targets, on average 350 targets per miRNA, as well as appropriate precision 
and sensitivity. 
Enrichment analysis of miRNA gene targets within the Wnt pathway was performed 
under the selection of KEGG pathway mmu04310. This enrichment utilizes the one-tailed 
Fisher’s exact test algorithm. This algorithm was chosen as it is used to detect enriched pathways 
with targets of specific miRNAs, exempting depleted pathways, is appropriate for small number 
statistics, and provides exact probabilities.  
3.3.2 Validation of predicted miRNA targeted genes within the Wnt pathway  
Validations of 6 predicted target genes within Wnt pathway selected from the Wnt 
signaling cascade: Wnts and Wnt antagonists (Wnt11, Sfrp1), Signaling transduction genes (Lrp1, 
APC, β-catenin) and downstream genes (Axin 2), were performed using Real-Time PCR. Total 
RNA was extracted from frozen tissue using Trizol (Invitrogen, ThermoFisher Scientific) and 
purified using the RNeasy Mini Cleanup kit (Qiagen, Valencia, CA, USA). cDNA was then 
synthesized with SuperScript III (Invitrogen, Carlsbad, CA, USA). Real-time PCR was 
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performed on the ViiA™ 7 Real-Time PCR System (Applied Biosystems, Foster City, CA). 
Primer sequences were listed in supplementary Data (Table S2).  
3.4 Interaction of microRNA and Wnt pathway 
Gene target prediction data was visualized using Cytoscape v3.3, an open source 
bioinformatic software platform for visualizing molecular interaction networks and biological 
pathways and integrating these networks with annotations, gene expression profiles and other 
state data. The Wnt KEGG pathway for Mus musculus was downloaded from the KEGG pathway 
database (http://www.kegg.jp/kegg/pathway.html) and imported into Cytoscape using the 
KEGGscape application. Predicted miRNA-gene target interactions were then uploaded using 
data generated with DIANA-miRPath v2.0. 
3.5 Statistical analysis 
 Data are expressed as means ± SEM. Data analysis was performed using SAS (Version 9.4, 
SAS Institute, Cary, NC). Comparisons between groups were made with a T-test. Significance 
was accepted when p < 0.05, and a false discovery rate cutoff of q < 0.2 was used when multiple 
comparisons were conducted. Heatmap was created based on transformed z-score values using R 
program.    
 For the miRNA and Wnt pathway related expression data analysis, the expression of each 
gene was normalized to the housekeeping genes, small RNAs (SnoRNA or 5s rRNA), or 
GAPDH (Cttarget gene-Cthousekeeping). Statistical analyses were performed based on ΔCt. The relative 
gene expression in the multiple one-carbon vitamin deplete group comparing to the replete 
control group were reported as 2−ΔΔCt, where ΔΔCt=CtMVD-CtControl.  
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CHAPTER 4 
RESULTS 
4.1 Tumor incidence and multiplicity increased in mice fed a multiple one-carbon vitamin 
deficient diet 
The number of tumors in the small intestine and colon, which were assessed in a blinded 
fashion, was significantly different between the control group and the vitamin deplete group 
(Table 2). In the control group, tumors were observed in 5 out of 10 mice, whereas 10 out of 11 
mice possessed tumors in the deplete group (p = 0.064). Tumor multiplicity, which indicates the 
number of tumors per mouse, was significantly greater (p = 0.028) in the deplete group than in 
the controls.  To limit the cost, only 8 animals per group were selected for the follow-up miRNA 
assays and the tumor incidence and multiplicity of these animals were shown in the parentheses 
in Table 2.  
 
Table 2 Influences on tumorigenesis. The effect of one-carbon vitamin deficiencies 
on tumor incidence (percentage of mice bearing tumors) and tumor multiplicity 
(average number of tumors per mouse in each group) in Apc1638N mice. 
Diet 
Tumor 
Incidence 
Tumor 
Multiplicity 
CTRL 
5/10 
(3/8)* 
0.500 
(0.375) 
MVD 
10/11 
(8/8) 
1.364 
(1.625) 
p_value 0.064 0.028 
* Numbers in the parentheses represent tumor incidence and tumor multiplicity of the mice in each 
group selected for the miRNA assays. CTRL: Control; MVD: Multiple Vitamin Depletion. 
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4.2 One-carbon vitamin deficiencies altered the microRNA expression profile in the colonic 
epithelium 
4.2.1 miRNAs identified from Affymetrix miRNA microarray   
The miRNA expression profiles were measured using Affymetrix miRNA microarrays on 
colonic epithelial cells from Apc1638N mice fed with one-carbon vitamin deficiencies (folate, 
vitamin B2, B6 and B12) or diets sufficient in those B-vitamins. Six miRNAs (miR-30e-3p, 
miR-122, miR-711, miR-541, miR-92b and miR-21) in a total of 609 examined to be 
significantly altered in MVD mice (p<0.05) with additional 9 microRNAs having a mild degree 
of alterations (p<0.10). The fold changes of these miRNAs were shown in Supplementary Data 
(Table S3) 
Following array analysis, samples were clustered according to their miRNA profile using 
the R software hierarchical clustering algorithm. Hierarchical clustering analysis revealed two 
distinct clusters, composing of those that are upregulated and those that are downregulated in 
MVD deficient mice when compared to controls. Upregulation of 7 miRNAs (miR-21, miR-711, 
miR-541, miR-30e-3p, miR-409-3p, miR-146a, miR-27a) was observed in MVD mice when 
compared to controls. In comparison we observed downregulation of 8 miRNA (miR-361, miR-
690, miR-31, miR-92a, miR-92b, miR-139a-3p, miR-125a-5p, miR-122) in MVD mice 
compared to controls (Figure 1).  
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Figure 1 Differential expression of miRNA. Changes in expression levels in miRNAs were 
induced by one-carbon vitamin deficiencies in Apc1638N mice when compared to controls. 15 
miRNA either significantly (p<0.05) or mildly altered (p<0.10) through one-carbon vitamin 
deficiencies were identified: 7 miRNAs (miR-21, miR-711, miR-541, miR-30e-3p, miR-409-3p, 
miR-146a, miR-27a) were upregulated in MVD mice when compared to controls. 8 miRNA 
were down regulated (miR-361, miR-690, miR-31, miR-92a, miR-92b, miR-139a-3p, miR-125a-
5p, miR-122) in MVD mice compared to controls. Heatmap was generated using Euclidean 
measure to obtain distance matrix and complete agglomeration method for hierarchical 
clustering. Green indicates upregulated expression, black indicates 0, and red indicates 
downregulated expression. 
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4.2.2Validation of microRNA array by real-time PCR 
For the two miRNAs (miR-122, and miR-21) whose expressions were identified by the 
Affymetrix miRNA microarray to be significantly changed between the control and one-carbon 
vitamin depletion group, our real-time PCR validation recapitulates the microarray data, and 
significant differences were identified (Figure 2). For those 3 miRNAs within the miR-29 family 
(miR-29a, miR-29b and miR-29c) whose expression were detected in the Affymetrix miRNA 
array, but the differences between the one-carbon vitamin depletion group and replete control 
group, our real-time PCR results showed a same pattern as the Affymetrix miRNA microarray 
data: the expression of all 3 miRNAs increased by the depletion of one-carbon vitamins, but the 
real-time PCR detected a statistical significant increase for miR-29c (p=0.045), and a mild 
degree (p=0.060) of increase for miR-29b (Figure 3). For the 3 miRNAs within  the family of 
miR-34 (miR-34a, miR-34b and miR-34c), the signals of which were below the detectable level 
in the Affymetrix microarray, our real-time PCR results showed a significant decrease (p < 0.05) 
of the miR-34c expression in the MVD group (Figure 4).   
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Figure 2. Relative expression of miR-122 and miR-21 in colonic samples from mice with 
and without multiple one-carbon deficiencies from real-time PCR and Affymetrix 
microarray Analysis. A) Real-time PCR results. One-carbon vitamin deficiencies resulted in a 
60% decrease in expression of miR-122 (p=0.027) and a 40% increase in miR-21 expression 
(p=0.028). B) Affymetrix miRNA microarray results. One-carbon vitamin deficiencies decreased 
expression of miR-122 by 90% (p=0.011) and increased expression of miR-21 by 50% 
(p=0.042).  
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Figure 3. Relative expression of the miR-29 family in colonic samples from mice with and 
without multiple one-carbon deficiencies from real-time PCR and Affymetrix microarray 
analysis. A) Real-time PCR results. One-carbon vitamin deficiencies resulted in increased 
expression of miR-29a by 20% (not significant), miR-29b by 50% (not significant) and miR-34c 
by 50% (p=0.045) B) Affymetrix miRNA microarray results. Increased expression was observed 
in all miR-29 family members, however this increase was not significant.  
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Figure 4. Relative expression of the miR-34 family in colonic samples from mice with and 
without multiple one-carbon vitamin deficiencies from real-time PCR analysis. One-carbon 
vitamin deficiencies decreased expression of miR-34c by 50% (p=0.044).  
 
4.3 The prediction of microRNA targets within the Wnt pathway  
4.3.1 Predicted miRNA target genes. 
A total of 18 miRNAs, including those 15 miRNA which were shown to be either 
significantly (p < 0.05) or mildly altered (p< 0.10) in the Affymetrix miRNA microarray data, 
plus miR-29b, miR-29c and miR-34c identified to be significantly (p < 0.05) or mildly (p< 0.10) 
by real-time PCR, were assessed for gene targets within the Wnt pathway using the DIANA 
mirPath tool. A total 2,074 total predicted gene targets across 85 different pathways,  of which 
15 of 18 miRNA tested were shown to have a total of 40 gene targets within the Wnt pathway 
(p<0.05). Of the 40 predicted genes, 26 are associated with canonical β-catenin pathway, 12 are 
associated with the PCP pathway and 14 are associated with the Ca2+ pathway (Figure 5). A 
detailed list of those miRNAs and their target genes within the Wnt pathway is shown in the 
Supplementary data (Table S4).  
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Figure 5. microRNA gene targets within the Wnt signaling pathway. 18 significantly altered 
(P<0.05) or mildly altered (P<0.10) miRNA in Apc1638N mice fed a one-carbon vitamin deficient 
diet are predicted to have a total of 40 gene targets within the Wnt pathway (P<0.05). Targets 
were predicted using gene target sequences from both 3′-UTR and protein coding sequence in 
silico using DIANA microT-CDS. KEGG pathway enrichment was performed using a one-tailed 
Fisher’s exact test and corrected for false discovery rate. No Wnt signaling associated gene 
targets were predicted for miR-122, miR-139 or miR-541. Three previously validated Wnt 
signaling associated gene targets for miR-122 were found when using DIANA Tarbase: Camk2b, 
Ccnd1 and Smad4. 14 miRNA are shown in fuchsia, targeting is shown by red arrows, predicted 
gene targets are shown in yellow. 
4.3.2 Validation of the microRNA predicted genes within the Wnt pathway  
To experimentally validate the in silico predicted miRNA target genes, we measured 6 
target genes selected from the Wnt signaling cascade: Wnts and Wnt antagonists (Wnt11, Sfrp1), 
Signaling transduction genes (Lrp1, APC, β-catenin) and downstream genes (Axin2) with real-
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time PCR using the ViAATM 7 PCR system (Applied Biosystems, Carlsbad, CA). Our results 
showed that one-carbon vitamin deficiencies elevated the expressions of β-catenin (p < 0.05) and 
increased the expression of the Wnt pathway downstream gene, Axin2, to a less degree (p = 
0.054). We also observed, the expression of SFRP1 was inhibited (p < 0.05). The overall 
expressions of the Wnt pathway-specific target genes examined altered in a fashion indicating the 
activation of Wnt signaling (Figure 6).  
 
Figure 6. Relative Expression of miRNA target genes within the Wnt signaling cascade 
associated in colonic samples from mice with and without multiple one-carbon vitamin 
deficiencies determined by real-time PCR. One-carbon deficiencies increased expression of β-
catenin and Axin2 4.4-folds (p < 0.05) and 2.5 folds (p=0.054) respectively, whereas decreased 
the expression of SFRP1 by 2.9 folds (p < 0.05) (Control n=8 mice; MVD n=8 mice).   
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CHAPTER 5 
DISCUSSION 
Over the past decade, the functions of miRNAs have been intensively investigated, and it 
is well-accepted now that miRNA regulate a variety of biological processes including 
development, metabolism, cell differentiation, proliferation and apoptosis, and thereby contribute 
to nearly all types of diseases including cancer (Jiang 2009). Our prior studies demonstrated the 
depletion of one-carbon metabolism related B-vitamins, including folate, riboflavin, vitamin B6 
and B12, induced a genomic DNA hypomethylation and an elevation of the tumorigenic Wnt 
signaling in mouse colonic epithelium. The present study showed that the combined 
inadequacies of those one-carbon vitamins alters the expressions of a number of miRNAs, and an 
in silico bioinformatic analysis indicated that multiple components within the Wnt signaling 
cascade are targeted by those miRNAs identified. These findings indicate that miRNAs may 
constitute a mechanism by which one-carbon B-vitamin depletions regulate the Wnt signaling 
pathway and thereby inform intestinal tumorigenesis.  
In this study, using the miRNA microarray (GeneChip miRNA Array v. 1.0, Affymetrix) 
which contained 609 mouse miRNAs, 208 miRNAs were detected in at least 4 samples out of the 
total of 6 samples examined. Among these miRNAs, we identified 6 miRNAs (miR-30e-3p, 
miR-122, miR-711, miR-541, miR-92b and miR-21) to be significantly altered in the B-vitamin 
deplete group (p < 0.05) with additional 9 miRNAs having a mild degree of alterations (p < 
0.10), indicating that only ~3% miRNAs were significantly altered by one-carbon vitamin 
depletions with additional ~4% miRNAs altered in a mild degree. Though the total percentage of 
miRNAs identified to be altered is not high, the data is consistent with prior studies which also 
showed a methyl deficient diet altered 1~7%  miRNAs in liver (Kutay 2006) (Tryndyak 2009) 
(Dolganiuc 2009).  
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To validate the miRNA microarray data, we performed real-time PCR individually for 2 
miRNAs (miR-21 and miR-122) which were identified to be significantly altered by the 
microarray,  3 miRNAs (miR-29a, miR-29b, and miR-29c) whose signals were detectable in the 
microarray, but not significantly different between the B-vitamin deplete and replete groups, and 
3 miRNAs (miR-34a, miR-34b, and miR-34c) whose signals were not detectable in the array.  
Consistent with the microarray data, significant differences were detected for miR-21 and miR-
122 by real-time PCR. For the miR-29 family, our real-time PCR measurement showed a similar 
pattern with the microarray data, but the differences between the dietary treatments reached to be 
significant or mildly significant for miR-29c (p = 0.045) and miR-29b (p = 0.060). For miR-34 
family, the real-time PCR identified the expression of miR-34c was significantly downregulated 
by one-carbon vitamin depletion (p = 0.044). We performed real-time PCR on 8 samples per 
group rather than 3 samples per group for the microarrays, and the sample size increased the 
power to statistically identify the differences. Nevertheless, new miRNAs continue to be defined 
and up to date there are 1915 mature miRNAs are discovered (www.miRBase.org, access on 
March 18, 2016). It should be expected that there are more miRNAs whose expressions may be 
regulated by one-carbon vitamins.  
Here we present a novel miRNA expression profile for murine colonic epithelial tissue in 
animals fed a one-carbon vitamin deficient diet. Interestingly we find significant upregulation of 
miR-21 in both microarray and PCR analysis.  When compared to other miRNA, miR-21 has 
been studied with notable depth, particularly as an oncogene in CRC.  miR-21 has been 
established as a reliable prognostic marker (Kjaer-Frifeldt 2012) (Zhang 2013), is a significant 
predictor of survival (Nielsen 2011) and has multiple validated tumor suppressor gene targets in 
CRC (Allgayer 2009) (Wang 2009e) (Cottonham 2010) (Chang 2011) (Yu 2011) (Ferraro 2014). 
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Wnt associated gene target prediction for miR-21 conferred predicted homology for a single 
gene, Dkk2. In vitro expression of Dkk2 has previously been shown to be significantly 
downregulated by overexpression miR-21 human tongue cancer cell line SCC25 (Kawakita 
2014). 
Another miRNA identified by both microarray and real-time PCR is miR-122.  However, 
our in silico prediction did not find any targets within the Wnt pathway for miR-122. Target 
prediction using DIANA microT-CDS which utilizes 3’-UTR and protein coding sequence data 
from miRBase version 18 and Ensembl version 69 to generate a miRNA-gene target interaction 
score yielded zero results. This was particularly surprising as current research suggests miR-122 
acts as a tumor suppressor through direct targeting of the Wnt ligand (Xu 2012) (Wang 2014a). 
In both glioma (Wang 2014a) and hepatocellular carcinoma miR-122 (Xu 2012) has been shown 
to directly target Wnt1 with an identified target binding site in the 3’-UTR. This result is not 
limited to DIANA microT-CDS; other well established tools such as Targetscan v7.0 
(http://www.targetscan.org/) and miRanda (http://www.microrna.org/microrna) did not predict 
Wnt1 as a top 1000 targets either (data not shown). However, target prediction using DIANA 
Tarbase v6.0, which utilizes verified gene targets, yielded three genes: Camk2b, Ccnd1 and 
Smad4 but did not include Wnt1 (data not shown). These findings suggest there are limitations to 
the use of in silico miRNA gene target prediction tools, even when gene targets have been 
previously verified. 
With the limitations of in silico miRNA gene target prediction in mind, we 
experimentally validated 6 genes selected from sections of the Wnt signaling cascade: Wnts/Wnts 
antagonists, signaling transduction genes, and downstream genes. Our results showed that the 
expression of Sfrp1 was inhibited (p < 0.05). Sfrp1, a Wnt signaling antagonist, has been 
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previously shown to be downregulated in CRC (Caldwell 2006), which is agreement with our 
speculation that one-carbon vitamin depletions upregulated Wnt signaling and thereby contribute 
to intestinal tumorigenesis. Another component which was experimentally validated is β-catenin, 
the accumulation and stabilization of which is critical in canonical Wnt signaling activation 
(Klaus 2008). Axin2, a downstream indicator of Wnt signaling, was marginally elevated (p = 
0.054) in the one-carbon vitamin deficient group. The expression change of the remaining 3 
genes were not experimentally validated. However, it is noteworthy that the expression changes 
of these genes by those B-vitamin depletion exhibit a pattern indicating the activation of Wnt 
signaling; the inhibition of Sfrp1, the Wnt antagonist, the elevation of β-catenin, a Wnt signaling 
transduction key component, and the mildly increased expression of Axin2, a downstream 
indicator of Wnt signaling.  
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CHAPTER 6 
CONCLUSIONS 
Overall, this study provides novel insight into the mechanisms of dietary modulation of 
colorectal cancer with a focus on one-carbon metabolism related vitamins driving alterations of 
miRNA expression which thereby regulate the tumorigenic Wnt pathway.  By implementing a 
combinatorial approach to quantify in vivo differential expression of miRNAs through both 
microarray and Real-time PCR, and in silico prediction of miRNA targets, we demonstrated that 
the combined inadequacies of one-carbon vitamins including folate, riboflavin, vitamin B6 and 
B12 is sufficient to induce differential expression of miRNAs, which in consequence post-
transcriptionally regulate genes within the Wnt signaling pathway.  
This study presents a miRNA expression profile showing 18 miRNAs found to be either 
significantly (p < 0.05) or mildly (p < 0.10) differentially expressed in the colonic epithelium of 
mice fed the depleted diet when compared to the counterpart. In silico prediction of the targets of 
those 18 miRNAs identified 40 genes within the Wnt pathway to have homology with miRNA 
seed sequences within their 3’-UTR or protein coding sequence. Of the 6 genes tested for 
experimentally target validation, the expression of Sfrp1 was shown to be significantly inhibited 
(p < 0.05) whereas β-catenin was shown to be significantly elevated (p < 0.05) with alterations of 
others in a fashion indicating the activation of Wnt signaling.  These findings indicate that 
miRNAs may constitute a mechanism by which one-carbon B-vitamin depletions regulate the 
Wnt signaling pathway and thereby induce intestinal tumorigenesis. In summary, this study sheds 
light on the molecular mechanisms by which inadequate intake of folate and other metabolically 
related B vitamins modulate colorectal cancer risk, and provides novel insights into the practice 
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of colorectal cancer prevention by dietary management of one-carbon metabolism related 
vitamins.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
56 
 
REFERENCES 
Aberle, H., Bauer,  a, Stappert, J., Kispert,  a, & Kemler, R. (1997). Beta-Catenin Is a Target for 
the Ubiquitin-Proteasome Pathway. The EMBO Journal, 16(13), 3797–3804. 
http://doi.org/10.1093/emboj/16.13.3797 
Ahmed, F. E., Ahmed, N. C., Vos, P. W., Bonnerup, C., Atkins, J. N., Casey, M., Allison, R. R. 
(2013). Diagnostic MicroRNA markers to screen for sporadic human colon cancer in stool: I. 
Proof of principle. Cancer Genomics and Proteomics, 10(3), 93–113. 
Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M, Warusavitarne, J. (2011). Molecular 
pathways in colorectal cancer. Journal of Gastroenterology and Hepatology. 27(9), 1423-31. 
Amersi, F., Agustin, M., & Ko, C. Y. (2005). Colorectal cancer: epidemiology, risk factors, and 
health services. Clinics in Colon and Rectal Surgery, 18(3), 133–40. http://doi.org/10.1055/s-
2005-916274 
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008). 
Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Letters, 267(1), 
133–164. http://doi.org/10.1016/j.canlet.2008.03.025 
Anton, R., Chatterjee, S. S., Simundza, J., Cowin, P., & DasGupta, R. (2011). A systematic 
screen for micro-RNAs regulating the canonical Wnt pathway. PLoS ONE, 6(10). 
http://doi.org/10.1371/journal.pone.0026257 
Arnold, C. N., Goel, A., Niedzwiecki, D., Dowell, J. M., Wasserman, L., Compton, C., Boland, 
C. R. (2004). APC Promoter Hypermethylation Contributes to the Loss of APC Expression in 
Colorectal Cancers with Allelic Loss on 5q. Cancer Biology & Therapy, 960–964. 
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & 
Allgayer, H. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor 
suppressor Pdcd4  and stimulates invasion, intravasation and metastasis in colorectal cancer. 
Oncogene, 27(15), 2128–2136. http://doi.org/10.1038/sj.onc.1210856 
Bafico, A., Gazit, A., Pramila, T., Finch, P. W., Yaniv, A., & Aaronson, S. A. (1999). Interaction 
of Frizzled Related Protein ( FRP ) with Wnt Ligands and the Frizzled Receptor Suggests 
Alternative Mechanisms for FRP Inhibition of Wnt Signaling. The Journal of Biological 
Chemistry, 274(23), 16180–16187. 
Bai, R., Weng, C., Dong, H., Li, S., Chen, G., & Xu, Z. (2015). MicroRNA-409-3p suppresses 
colorectal cancer invasion and metastasis partly by targeting GAB1 expression. International 
Journal of Cancer, 137(10), 2310–2322. http://doi.org/10.1002/ijc.29607 
 
57 
 
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramirez, N., … García-
Foncillas, J. (2006). Identification by Real-time PCR of 13 mature microRNAs differentially 
expressed in colorectal cancer and non-tumoral tissues. Molecular Cancer, 5, 29. 
http://doi.org/10.1186/1476-4598-5-29 
Bao, Y., Chen, Z., Guo, Y., Feng, Y., Li, Z., Han, W., Yang, W. (2014). Tumor suppressor 
MicroRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2. 
PLoS ONE, 9(8), 1–11. http://doi.org/10.1371/journal.pone.0105991 
Barker, N. 2014. Adult intestinal stem cells: critical drivers of epithelial homeostasis and 
regeneration. Nature Reviews Molecular Cell Biology, 15(1), 19-33. 
Beckett, E. L., Martin, C., Choi, J. H., King, K., Niblett, S., Boyd, L., Lucock, M. (2015). Folate 
status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a 
biomarker. BBA Clinical, 4, 45–51. http://doi.org/10.1016/j.bbacli.2015.06.006 
Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, 
W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature, 
382(6592), 638–642. http://doi.org/10.1038/382638a0 
Bhanot, P., Brink, M., Samos, C. H., Hsieh, J. C., Wang, Y., Macke, J. P., Nusse, R. (1996). A 
new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature, 
382(6588), 225–230. http://doi.org/10.1038/382225a0 
Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J., & Benz, C. C. (2008). 
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic 
potential in breast cancer cells. Oncogene, 27, 5643–5647. http://doi.org/10.1038/onc.2008.171 
Bishayee, A. (2009). Cancer Prevention and Treatment with Resveratrol : From Rodent Studies 
to Clinical Trials. Cancer Prevention Research, 2(May), 409–419. http://doi.org/10.1158/1940-
6207.CAPR-08-0160 
Bjerknes M, Cheng H. Methods for the isolation of intact epithelium from the mouse intestine. 
The Anatomical Record, 1981;199:565-74. 
Bohnsack, M. T., Czaplinski, K., & Go, D. (2004). Exportin 5 is a RanGTP-dependent dsRNA-
binding protein that mediates nuclear export of pre-miRNAs. RNA, 185–191. 
http://doi.org/10.1261/rna.5167604.Most 
Budhu, A., Jia, H. L., Forgues, M., Liu, C. G., Goldstein, D., Lam, A., Xin, W. W. (2008). 
Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology, 47(3), 
897–907. http://doi.org/10.1002/hep.22160 
58 
 
Bushati, N., & Cohen, S. M. (2007). microRNA Functions. Annual Review of Cell and 
Developmental Biology, 23(1), 175–205. 
http://doi.org/10.1146/annurev.cellbio.23.090506.123406 
Caldwell, G. M., Jones, C. E., Taniere, P., Warrack, R., Soon, Y., Matthews, G. M., & Morton, 
D. G. (2006). The Wnt antagonist sFRP1 is downregulated in premalignant large bowel 
adenomas. British Journal of Cancer, 94(6), 922–7. http://doi.org/10.1038/sj.bjc.6602967 
Cao, Y., Hu, J., Fang, Y., Chen, Q., & Li, H. (2014). Association between a functional variant in 
microRNA-27a and susceptibility to colorectal cancer in a Chinese Han population. Genetics and 
Molecular Research, 13(3), 7420–7427. 
Caudy, A. A., Hammond, S. M., Rauhut, R., Lendeckel, W., Lim, E. P., Weinstein, E. G., 
Baulcombe, D. C. (2002). A microRNA in a Multiple- Turnover RNAi Enzyme Complex. 
Science, 297(September), 2056–2061. 
Cekaite, L., Rantala, J. K., Bruun, J., Guriby, M., Agesen, T. H., Danielsen, S. A., … Skotheim, 
R. I. (2012). MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in 
colon cancer. Neoplasia, 14(9), 868–79. http://doi.org/10.1593/neo.121094 
Center, M. M., Jemal,  a., Smith, R. a., & Ward, E. (2010). Worldwide variations in colorectal 
cancer. Diseases of the Colon and Rectum, 53, 1099. 
http://doi.org/10.1007/DCR.0b013e3181d60a51 
Cha, Y. H., Kim, N. H., Park, C., Lee, I., Kim, H. S., & Yook, J. I. (2012). miRNA-34 
intrinsically links p53 tumor suppressor and Wnt signaling. Cell Cycle, 11(7), 1273–1281. 
http://doi.org/10.4161/cc.19618 
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005). MicroRNA-21 is an antiapoptotic factor 
in human glioblastoma cells. Cancer Research, 65(14), 6029–6033. http://doi.org/10.1158/0008-
5472.can-05-0137 
Chang, S., Gao, L., Yang, Y., Tong, D., Guo, B., & Liu, L. (2015). miR-145 mediates the 
antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric 
cancer cells. Oncotarget, 6(10). 
Chang, S. S., Jiang, W. W., Smith, I., Poeta, L. M., Begum, S., Glazer, C.,  Califano, J. A. 
(2008). MicroRNA alterations in head and neck squamous cell carcinoma. International Journal 
of Cancer, 123(12), 2791–7. http://doi.org/10.1002/ijc.23831 
Chatterjee, S., Fasler, M., & Bu, I. (2011). Short Article Target-Mediated Protection of 
Endogenous MicroRNAs in C . elegans. Developmental Cell, 7, 388–396. 
http://doi.org/10.1016/j.devcel.2011.02.008 
59 
 
Cheloufi, S., Dos Santos, C. O., Chong, M. M. W., & Hannon, G. J. (2010). A dicer-independent 
miRNA biogenesis pathway that requires Ago catalysis. Nature, 465(7298), 584–589. 
http://doi.org/10.1038/nature09092 
Chen, C. A., Zheng, D., Xia, Z., & Shyu, A. (2009). Ago – TNRC6 triggers microRNA-mediated 
decay by promoting two deadenylation steps. Nature Structural & Molecular Biology, 16(11), 
1160–1166. http://doi.org/10.1038/nsmb.1709 
Chen, P.-H., Shih, C.-M., Chang, W.-C., Cheng, C.-H., Lin, C.-W., Ho, K., … Chen, K.-C. 
(2014). MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-
induced glioma cell apoptosis. Journal of Neurochemistry, 131(6), 731–742. 
http://doi.org/10.1111/jnc.12820 
Ching, W., Hang, H. C., & Nusse, R. (2008). Lipid-independent Secretion of a Drosophila Wnt 
Protein. The Journal of Biological Chemistry, 283(25), 17092–17098. 
http://doi.org/10.1074/jbc.M802059200 
Choi, S. W., & Mason, J. B. (2000). Folate and carcinogenesis: an integrated scheme. The 
Journal of Nutrition, 130(2), 129–132. 
Chow, T.-F. F., Youssef, Y. M., Lianidou, E., Romaschin, A. D., Honey, R. J., Stewart, R., 
Yousef, G. M. (2010). Differential expression profiling of microRNAs and their potential 
involvement in renal cell carcinoma pathogenesis. Clinical Biochemistry, 43(1-2), 150–158. 
http://doi.org/10.1016/j.clinbiochem.2009.07.020 
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127(3), 469–
80. http://doi.org/10.1016/j.cell.2006.10.018 
Clifford, A. J., Wilson, D. S., and Bills, N. D. (1989) Repletion of folate-depleted rats with an 
amino acid-based diet supplemented with folic acid. Journal of Nutrition, 119, 1956-1961 
Connolly, E., Melegari, M., Landgraf, P., Tchaikovskaya, T., Tennant, B. C., Slagle, B. L., … 
Rogler, C. E. (2008). Elevated expression of the miR-17-92 polycistron and miR-21 in 
hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. 
American Journal of Pathology, 173(3), 856–864. http://doi.org/10.2353/ajpath.2008.080096 
Cottonham, C. L., Kaneko, S., & Xu, L. (2010). miR-21 and miR-31 converge on TIAM1 to 
regulate migration and invasion of colon carcinoma cells. Journal of Biological Chemistry, 
285(46), 35293–35302. http://doi.org/10.1074/jbc.M110.160069 
Cruciat, C., & Niehrs, C. (2013). Secreted and Transmembrane Wnt Inhibitors and Activators. 
Cold Spring Harbor Perspectives in Biology. 1;5(3):a015081. doi: 10.1101/cshperspect.a015081. 
60 
 
Czech, B., Zhou, R., Erlich, Y., Brennecke, J., Binari, R., Villalta, C., Hannon, G. J. (2009). 
Hierarchical Rules for Argonaute Loading in Drosophila. Molecular Cell, 36(3), 445–456. 
http://doi.org/10.1016/j.molcel.2009.09.028 
Dahmke, I. N., Backes, C., Rudzitis-auth, J., Laschke, M. W., Leidinger, P., Menger, M. D., 
Mahlknecht, U. (2013). Curcumin Intake Affects miRNA Signature in Murine Melanoma with 
mmu-miR-205-5p Most Significantly Altered, PLoS ONE, 8(12), 1–10. 
http://doi.org/10.1371/journal.pone.0081122 
Dann, C. E., Hsieh, J., Rattner, A., & Sharma, D. (2001). Insights into Wnt binding and 
signalling from the structures of two Frizzled cysteine-rich domains. Nature, 412(6842), 86-90. 
Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Niehrs, C. (2005). Casein 
kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature, 
438(7069), 867–872. http://doi.org/10.1038/nature04170 
Davis, C. D., & Uthus, E. O. (2004). DNA methylation, cancer susceptibility, and nutrient 
interactions. Experimental Biology and Medicine, 229(10), 988–995. 
de la Chapelle, A. (2004). Genetic predisposition to colorectal cancer. Nature Reviews Cancer, 
4(10), 769–780. http://doi.org/10.1038/nrc1453 
Ding, L., & Han, M. (2007). GW182 family proteins are crucial for microRNA-mediated gene 
silencing. Trends in Cell Biology, 17(8), 6–11. http://doi.org/10.1016/j.tcb.2007.06.003 
Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A, Szabo G. (2009). 
MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline 
deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcoholism, Clinical and 
Experimental Research, 33(10):1704-10.  
Duester, G. (2008). Retinoic acid synthesis and signaling during early organogenesis. Cell, 
134(6), 921–931. http://doi.org/10.1016/j.cell.2008.09.002 
Durko, L., & Malecka-Panas, E. (2014). Lifestyle Modifications and Colorectal Cancer. Current 
Colorectal Cancer Reports, 10(1), 45–54. http://doi.org/10.1007/s11888-013-0203-4 
Edwards, B. K., Ward, E., Kohler, B. a, Zauber, A. G., Anderson, R. N., Jemal, A., Seeff, L. C. 
(2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal 
cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future 
rates. Cancer, 116(3), 544–573. http://doi.org/10.1002/cncr.24760 
 Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001). RNA interference is mediated by 21- and 
22-nucleotide RNAs. Genes & Development, 188–200. http://doi.org/10.1101/gad.862301.vents 
61 
 
Etoh, T., Kanai, Y., Ushijima, S., Nakagawa, T., Nakanishi, Y., Sasako, M., … Hirohashi, S. 
(2004). Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly 
with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands 
in gastric cancers. The American Journal of Pathology, 164(2), 689–99. 
http://doi.org/10.1016/S0002-9440(10)63156-2 
Fabian, M. R., & Sonenberg, N. (2012). The mechanics of miRNA-mediated gene silencing: a 
look under the hood of miRISC. Nature Structural & Molecular Biology, 19(6), 586–593. 
http://doi.org/10.1038/nsmb.2296 
Fang, C. Y., Wu, C. C., Hsu, H. Y., & Chuang, H. Y. (2015). EGCG Inhibits Proliferation , 
Invasiveness and Tumor Growth by Up-Regulation of Adhesion Molecules , Suppression of 
Gelatinases Activity , and Induction of Apoptosis in Nasopharyngeal Carcinoma Cells. 
International Journal of Molecular Sciences. 1661, 2530–2558.  
Fearon, E. R. (2011). Molecular Genetics of Colorectal Cancer. Annual Review of Pathology: 
Mechanisms of Disease, 6(1), 479–507. http://doi.org/10.1146/annurev-pathol-011110-130235 
Ferraro, A., Kontos, C. K., Boni, T., Bantounas, I., Siakouli, D., Kosmidou, V., Pintzas, A. 
(2014). Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target 
and a three-gene network (miR-21-ITGB44-PCDC4) as predictor of metastatic tumor potential. 
Epigenetics, 9(1), 129–141. http://doi.org/10.4161/epi.26842 
Ferretti, E., De Smaele, E., Po, A., Marcotullio, L. Di, Tosi, E., Espinola, M. S. B., Gulino, A. 
(2009). MicroRNA profiling in human medulloblastoma. International Journal of Cancer, 
124(3), 568–577. http://doi.org/10.1002/ijc.23948 
Filipowicz, W., Bhattacharyya, S. N., & Sonenberg, N. (2008). Mechanisms of post-
transcriptional regulation by microRNAs : are the answers in sight? Nature Reviews. Genetics, 
9(2):102-14. http://doi.org/10.1038/nrg2290 
Fodde, R., Smits, R., & Clevers, H. (2001). APC, signal transduction and genetic instability in 
colorectal cancer. Nature Reviews. Cancer, 1(1), 55–67. http://doi.org/10.1038/35094067 
Foley, N. H., Bray, I., Watters, K. M., Das, S., Bryan, K., Bernas, T., Stallings, R. L. (2011). 
MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through 
targeting of nuclear receptor corepressor 2. Cell Death and Differentiation, 18(7), 1089–1098. 
http://doi.org/10.1038/cdd.2010.172 
Fulci, V., Chiaretti, S., Goldoni, M., Azzalin, G., Carucci, N., Tavolaro, S.,  Macino, G. (2007). 
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. 
Blood, 109(11), 4944–4951. http://doi.org/10.1182/blood-2006-12-062398 
62 
 
Gan, H. H., & Gunsalus, K. C. (2015). Assembly and analysis of eukaryotic Argonaute – RNA 
complexes in microRNA-target recognition. Nucleic Acids Research, 43(20):9613-25. 
http://doi.org/10.1093/nar/gkv990 
Gao, S., Yang, J., Chen, C., Chen, J., Ye, L., Wang, L., & Wu, J. (2012). Pure curcumin 
decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. 
Journal of Experimental & Clinical Cancer Research, 31(1), 27. http://doi.org/10.1186/1756-
9966-31-27 
Garzon, R., Pichiorri, F., Palumbo, T., Visentini, M., Aqeilan, R., Cimmino, A., … Croce, C. M. 
(2007). MicroRNA gene expression during retinoic acid-induced differentiation of human acute 
promyelocytic leukemia. Oncogene, 26(28):4148-57. http://doi.org/10.1038/sj.onc.1210186 
Giangreco, A. A., Vaishnav, A., Wagner, D., Finelli, A., Fleshner, N., Kwast, T. Van Der, … 
Nonn, L. (2013). Tumor Suppressor microRNAs , miR-100 and -125b , Are Regulated by 1 , 25-
dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue. Cancer Prevention 
Research, 6(5):483-94. http://doi.org/10.1158/1940-6207.CAPR-12-0253 
Gillis, A. J. M., Stoop, H. J., Hersmus, R., Oosterhuis, J. W., Sun, Y., Chen, C., Looijenga, L. H. 
J. (2007). High-throughput microRNAome analysis in human germ cell tumours. The Journal of 
Pathology, 213(3), 319–328. http://doi.org/10.1002/path.2230 
Giovannucci, E. (2002). Epidemiologic studies of folate and colorectal neoplasia: a review. 
Journal of Nutrition, 132(8 Suppl), 2350S–2355S. 
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998). 
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. 
Nature, 391(6665):357-62. 
Gokhale, A., Kunder, R., Goel, A., Sarin, R., Moiyadi, A., Shenoy, A., … Shirsat, N. V. (2010). 
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling 
pathway. Journal of Cancer Research and Therapeutics, 6(4), 521–529. 
http://doi.org/10.4103/0973-1482.77072 
Gu, S., Jin, L., Zhang, F., Sarnow, P., & Kay, M. A. (2009). Biological basis for restriction of 
microRNA targets to the 3' untranslated region in mammalian mRNAs. Nature Structural and 
Molecular Biology, 16(2), 144–150. http://doi.org/10.1038/nsmb.1552.The 
Guo, X., Wu, Y., & Hartley, R. S. (2009). MicroRNA-125a represses cell growth by targeting 
HuR in breast cancer. RNA Biology, 6(5), 575–583. http://doi.org/10.4161/rna.6.5.10079 
Guttilla, I. K., & White, B. A. (2009). Coordinate regulation of FOXO1 by miR-27a, miR-96, 
and miR-182 in breast cancer cells. Journal of Biological Chemistry, 284(35), 23204–23216. 
http://doi.org/10.1074/jbc.M109.031427 
63 
 
Haggar, F. a, Boushey, R. P. (2009). Colorectal Cancer Epidemiology : Incidence , Mortality , 
Survival , and Risk Factors. Clinics in Colon and Rectal Surgery, 6(212), 191–197. 
http://doi.org/10.1055/s-0029-1242458. 
Han, J., Lee, Y., Yeom, K., Nam, J., Heo, I., Rhee, J., Kim, V. N. (2006). Molecular Basis for 
the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex. Cell, 125(5):887-901. 
http://doi.org/10.1016/j.cell.2006.03.043 
Hart, M., Concordet, J. P., Lassot, I., Albert, I., del los Santos, R., Durand, H., Polakis, P. (1999). 
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its 
activity in the cell. Current Biology : CB, 9(4), 207–210. 
Haug, B. H., Henriksen, J. R., Buechner, J., Geerts, D., Tomte, E., Kogner, P., … Einvik, C. 
(2011). MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 
(DKK3) in neuroblastoma. Carcinogenesis, 32(7), 1005–1012. 
http://doi.org/10.1093/carcin/bgr073 
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Takahashi, 
T. (2005). A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung 
cancers and enhances cell proliferation. Cancer Research, 65(21), 9628–9632. 
http://doi.org/10.1158/0008-5472.CAN-05-2352 
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Hammond, 
S. M. (2005). A microRNA polycistron as a potential human oncogene. Nature, 435(7043), 828–
33. http://doi.org/10.1038/nature03552 
He, T. C., Sparks,  a B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., … Kinzler, K. W. 
(1998). Identification of c-MYC as a target of the APC pathway. Science, 281(5382), 1509–
1512. http://doi.org/10.1126/science.281.5382.1509 
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004). LDL receptor-related proteins 5 and 6 in 
Wnt/beta-catenin signaling: arrows point the way. Development, 131(8), 1663–1677. 
http://doi.org/10.1242/dev.01117 
Hoang, B., Moos, M., Vukicevic, S., Luyten, F. P., & Chem, M. J. B. (1996). Primary Structure 
and Tissue Distribution of FRZB , a Novel Protein Related to Drosophila Frizzled, Suggest a 
Role in Skeletal Morphogenesis. Journal of Biological Chemistry,  271(42), 26131–26137. 
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, 
Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. (2015). SEER 
Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, 
http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted 
to the SEER web site, April 2015. 
64 
 
Hsieh, J., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Harryman, C., 
Nathans, J. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activites 
with mature somites, but not with unsegmented paraxial mesoderm. Nature, 398(6726), 431–
436. 
Ishitani, T., Ninomiya-tsuji, J., Nagai, S., Nishita, M., Meneghini, M., Barker, N., Matsumoto, K. 
(1999). The TAK1-NLK-MAPK- related pathway antagonizes signalling between b -catenin and 
transcription factor TCF. Nature, 399(6738), 798–802. 
Ito, M., Mitsuhashi, K., Igarashi, H., Nosho, K., Naito, T., Yoshii, S., Shinomura, Y. (2014). 
MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal 
continuum in serrated lesions. International Journal of Cancer, 135(11), 2507–2515. 
http://doi.org/10.1002/ijc.28920 
Iwasaki, S., Kobayashi, M., Yoda, M., Sakaguchi, Y., Katsuma, S., & Suzuki, T. (2010). Short 
Article Hsc70 / Hsp90 Chaperone Machinery Mediates ATP-Dependent RISC Loading of Small 
RNA Duplexes. Molecular Cell, 39(2), 292–299. http://doi.org/10.1016/j.molcel.2010.05.015 
Jasperson KW, Burt RW. APC-Associated Polyposis Conditions. 1998 Dec 18 [Updated 2014 
Mar 27]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. 
Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: 
https://www.ncbi.nlm.nih.gov/books/NBK1345/  
Janda, C. Y., Waghray, D., Levin, A. M., Thomas, C., & Garcia, K. C. (2012). Structural Basis 
of Wnt Recognition by Frizzled, 1–7. Science, 337(6090):59-64.  
Jemal, A., Bray, F., & Ferlay, J. (1999). Global Cancer Statistics: 2011. CA: A Cancer Journal 
for Clinicians, 49(2), 1,33–64. http://doi.org/10.3322/caac.20107.Available 
Jiang, Q., Wang, Y., Hao, Y., Juan, L., Teng, M., Zhang, X., … Liu, Y. (2009). miR2Disease: A 
manually curated database for microRNA deregulation in human disease. Nucleic Acids 
Research, 37(SUPPL. 1), 98–104. http://doi.org/10.1093/nar/gkn714 
Joglekar, M. V., Patil, D., Joglekar, V. M., Rao, G. V., Reddy, D. N., Mitnala, S., Hardikar, A. 
A. (2009). The miR-30 family microRNAs confer epithelial phenotype to human pancreatic 
cells. Islets, 1(2), 137–147. http://doi.org/10.4161/isl.1.2.9578 
Jones, P. A. (2002). DNA methylation and cancer. Oncogene, 21(35), 5358–5360. 
http://doi.org/10.1038/sj.onc.1205597 
Josson, S., Gururajan, M., Hu, P., Shao, C., Chu, G. C. Y., Zhau, H. E., Chung, L. W. K. (2014). 
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone 
metastasis of human prostate cancer. Clinical Cancer Research , 20(17), 4636–4646. 
http://doi.org/10.1158/1078-0432.CCR-14-0305 
65 
 
Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM. miR-29 modulates Wnt signaling in 
human osteoblasts through a positive feedback loop. Journal of Biological Chemistry, 285 (33), 
25221-31. 
Kawakita, A., Yanamoto, S., Yamada, S.-I., Naruse, T., Takahashi, H., Kawasaki, G., & Umeda, 
M. (2014). MicroRNA-21 promotes oral cancer invasion via the Wnt/beta-catenin pathway by 
targeting DKK2. Pathology Oncology Research : POR, 20(2), 253–261. 
http://doi.org/10.1007/s12253-013-9689-y 
Kawamata, T., & Tomari, Y. (2010). Making RISC. Trends in Biochemical Sciences, 35(7), 
368–376. http://doi.org/10.1016/j.tibs.2010.03.009 
Khan, S., Wall, D., Curran, C., Newell, J., Kerin, M. J., & Dwyer, R. M. (2015). MicroRNA-10a 
is reduced in breast cancer and regulated in part through retinoic acid. BMC Cancer, 15, 345. 
http://doi.org/10.1186/s12885-015-1374-y 
Kim, N. H., Cha, Y. H., Kang, S. E., Lee, Y., Lee, I., Cha, S. Y., Kim, H. S. (2013). p53 
regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer 
cells. Cell Cycle, 12(10), 1578–1587. http://doi.org/10.4161/cc.24739 
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Weiss, S. J. (2011). p53 and 
microRNA-34 are suppressors of canonical Wnt signaling. Science Signaling, 4(197), ra71. 
http://doi.org/10.1126/scisignal.2001744 
Kim, Y. I., Shirwadkar, S., Choi, S. W., Puchyr, M., Wang, Y., & Mason, J. B. (2000). Effects of 
dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. 
Gastroenterology, 119(1), 151–161. 
Kjaer-Frifeldt, S., Hansen, T. F., Nielsen, B. S., Joergensen, S., Lindebjerg, J., Soerensen, F. B., 
Jakobsen,  a. (2012). The prognostic importance of miR-21 in stage II colon cancer: a 
population-based study. British Journal of Cancer, 107(7), 1169–74. 
http://doi.org/10.1038/bjc.2012.365 
Kogo, R., Mimori, K., Tanaka, F., Komune, S., & Mori, M. (2011). Clinical significance of miR-
146a in gastric cancer cases. Clinical Cancer Research, 17(13), 4277–4284. 
http://doi.org/10.1158/1078-0432.CCR-10-2866 
Komekado, H., Yamamoto, H., Chiba, T., & Kikuchi, A. (2007). Glycosylation and 
palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes to Cells, (4), 
521–534. http://doi.org/10.1111/j.1365-2443.2007.01068.x 
 
66 
 
Krek, A., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., Grun, D., Rajewsky, N. (2005). 
Combinatorial microRNA target predictions. Nature Genetics, 37(5), 495–501. 
http://doi.org/10.1038/ng1536 
Kronski, E., Fiori, M. E., Barbieri, O., Astigiano, S., Mirisola, V., Killian, P. H., Bachmeier, B. 
E. (2014). miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast 
cancer metastasis via down- regulation of the inflammatory cytokines CXCL1 and -2. Molecular 
Oncology, 8(3), 581–595. http://doi.org/10.1016/j.molonc.2014.01.005 
Kurayoshi, M., Yamamoto, H., Izumi, S., & Kikuchi, A. (2007). Post-translational 
palmitoylation and glycosylation of Wnt-5a are necessary. The Biochemical Journal, 402(3):515-
23. http://doi.org/10.1042/BJ20061476 
Kutay, H., Bai, S., Datta, J., Motiwala, T., Pogribny, I., Frankel, W., Ghoshal, K. (2006). 
Downregulation of miR-122 in the Rodent and Human Hepatocellular Carcinomas. Journal of 
Cellular Biochemistry, 99(3):671-8. http://doi.org/10.1002/jcb.20982. 
Lawrie, C. H., Soneji, S., Marafioti, T., Cooper, C. D. O., Palazzo, S., Paterson, J. C., Hatton, C. 
S. R. (2007). MicroRNA expression distinguishes between germinal center B cell-like and 
activated B cell-like subtypes of diffuse large B cell lymphoma. International Journal of Cancer, 
121(5), 1156–1161. http://doi.org/10.1002/ijc.22800 
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 
encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5), 843–54. 
http://doi.org/10.1016/0092-8674(93)90529-Y 
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Kim, V. N. (2003). The nuclear RNase III 
Drosha initiates microRNA processing. Nature, 425(6956):415-9. 
Lei, L., Huang, Y., & Gong, W. (2014). Inhibition of miR-92b suppresses nonsmall cell lung 
cancer cells growth and motility by targeting RECK. Molecular and Cellular Biochemistry, 
387(1-2), 171–176. http://doi.org/10.1007/s11010-013-1882-5 
Leyns, L., Bouwmeester, T., Kim, S., Piccolo, S., & Robertis, E. M. De. (1997). Frzb-1 Is a 
Secreted Antagonist of Wnt Signaling Expressed in the Spemann Organizer. Cell, 88(6):747-56. 
Li, Q., Shen, K., Zhao, Y., Ma, C., Liu, J., & Ma, J. (2013). MiR-92b inhibitor promoted glioma 
cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. Journal 
of Translational Medicine, 11, 302. http://doi.org/10.1186/1479-5876-11-302 
Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Clevers, H. 
(2012a). Wnt Signaling through Inhibition of b -Catenin Degradation in an Intact Axin1 
Complex. Cell, 149(6), 1245–1256. http://doi.org/10.1016/j.cell.2012.05.002 
67 
 
Li, Y., VandenBoom, T. G., Wang, Z., Kong, D., Ali, S., Philip, P. A., & Sarkar, F. H. (2010). 
miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research, 70(4), 1486–1495. 
http://doi.org/10.1158/0008-5472.CAN-09-2792 
Li, Y., Vecchiarelli-Federico, L. M., Li, Y. J., Egan, S. E., Spaner, D., Hough, M. R., & Ben-
David, Y. (2012b). The miR-17-92 cluster expands multipotent hematopoietic progenitors 
whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. 
Blood, 119(19), 4486–4498. http://doi.org/10.1182/blood-2011-09-378687 
Lim, L. P., Lau, N. C., Garrett-engele, P., & Grimson, A. (2005). Microarray analysis shows that 
some microRNAs downregulate large numbers of target mRNAs. Nature, 433(7027):769-73. 
Lin, S., Chiang, A., Chang, D., & Ying, S. (2008). Loss of mir-146a function in hormone-
refractory prostate cancer Loss of mir-146a function in hormone-refractory prostate cancer. RNA, 
14, 417–424. http://doi.org/10.1261/rna.874808.surgery 
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G., Tan, Y. (2002). Control of β -Catenin 
Phosphorylation / Degradation by a Dual-Kinase Mechanism, Cell, 108(6):837-47. 
Liu, H., Fergusson, M. M., Castilho, R. M., Liu, J., Cao, L., Chen, J., Finkel, T. (2007b). Aug-
mented Wnt Signaling in a mammalian model of accelerated aging. Science, 317(5839):803-6 
Liu, M., Xu, A., Yuan, X., Zhang, Q., Fang, T., Wang, W., & Li, C. (2015). Downregulation of 
microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication 
for personalized medicine. Journal of Translational Medicine, 13, 195. 
http://doi.org/10.1186/s12967-015-0533-x 
Liu, T., Tang, H., Lang, Y., Liu, M., & Li, X. (2009). MicroRNA-27a functions as an oncogene 
in gastric adenocarcinoma by targeting prohibitin. Cancer Letters, 273(2), 233–242. 
http://doi.org/10.1016/j.canlet.2008.08.003 
Liu, X., Duan, B., Dong, Y., He, C., Zhou, H., Sheng, H., Zhang, X. (2014a). MicroRNA-139-3p 
indicates a poor prognosis of colon cancer. International Journal of Clinical and Experimental 
Pathology, 7(11), 8046–8052. 
Liu, Z., Choi, S. W., Crott, J. W., Keyes, M. K., Jang, H., Smith, D. E., Mason, J. B. (2007a). 
Mild depletion of dietary folate combined with other B vitamins alters multiple components of 
the Wnt pathway in mouse colon. Journal of Nutrition, 137(12), 2701–2708. 
Liu, Z., Ciappio, E. D., Crott, J. W., Brooks, R. S., Nesvet, J., Smith, D. E.,  Mason, J. B. (2011). 
Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote 
intestinal tumorigenesis in BAT-LacZxApc1638N mice. FASEB Journal, 25(9), 3136–3145. 
http://doi.org/10.1096/fj.11-184143 
68 
 
Liu, Z., S. Tammen, S. Friso, and SW Choi. "Crosstalk between MicroRNAs and Epigenetics: 
From the Nutritional Perspective." Ross, Sharon A., and Cindy D. Davis. "MicroRNA, Nutrition, 
and Cancer Prevention." Advances in Nutrition 2.6: 472-85. 1.1 (2014b). 
Logan, C. Y., & Nusse, R. (2004). The Wnt Signaling Pathway in Development and Disease. 
Annual Review of Cell and Developmental Biology, 20(1), 781–810. 
http://doi.org/10.1146/annurev.cellbio.20.010403.113126 
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sanchez-Cespedes, M., Blanco, D., 
Esteller, M. (2008). A microRNA DNA methylation signature for human cancer metastasis. 
Proceedings of the National Academy of Sciences of the United States of America, 105(36), 
13556–13561. http://doi.org/10.1073/pnas.0803055105 
Luo, X., Burwinkel, B., Tao, S., & Brenner, H. (2011). MicroRNA Signatures: Novel Biomarker 
for Colorectal Cancer? Cancer Epidemiology Biomarkers & Prevention, 20(7), 1272–1286. 
http://doi.org/10.1158/1055-9965.EPI-11-0035 
Ma, F., Song, H., Guo, B., Zhang, Y., Zheng, Y., Lin, C. Qiu, X. (2015). MiR-361-5p inhibits 
colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain 
containing-1. Oncotarget, 6(19), 17404–16. http://doi.org/10.18632/oncotarget.3744 
Ma, Y., Trump, D. L., & Johnson, C. S. (2014). Vitamin D and miRNAs in cancer. Current Gene 
Therapy, 14(4), 269–275. 
Mann, B., Gelos, M., Siedow, A., Hanski, M. L., Gratchev, A., Ilyas, M., Hanski, C. (1999). 
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human 
colorectal carcinomas. Proceedings of the National Academy of Sciences of the United States of 
America, 96(4), 1603–1608. 
Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C. (2001). LDL-receptor-related 
protein 6 is a receptor for Dickkopf proteins. Nature, 411(6835):321-5. 
Mao, Y., Li, Y., Jing, F., Cai, S., Zhang, Z., Li, Q., Chen, K. (2014). Association of a genetic 
variant in microRNA-146a with risk of colorectal cancer: a population-based case-control study. 
Tumor Biology, 35(7), 6961–6967. http://doi.org/10.1007/s13277-014-1916-y 
Marsit, C. J., Eddy, K., & Kelsey, K. T. (2006). MicroRNA responses to cellular stress. Cancer 
Research, 66(22), 10843–10848. http://doi.org/10.1158/0008-5472.CAN-06-1894 
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S., Young, 
R. a. (2008). Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of 
Embryonic Stem Cells. Cell, 134(3), 521–533. http://doi.org/10.1016/j.cell.2008.07.020 
Martinez, J., & Tuschl, T. (2004). RISC is a 5’ phosphomonoester-producing RNA 
endonuclease. Genes and Development, 18(9), 975–980. http://doi.org/10.1101/gad.1187904 
69 
 
Mason, J., Kitajewski, J., & Varmus, H. E. (1992). Mutational Analysis of Mouse Wnt-1 
Identifies Two Temperature-Sensitive Alleles and Attributes of Wnt-1 Protein Essential for 
Transformation of a Mammary Cell Line. Molecular Biology of the Cell, 3(5):521-33. 
Mathé, E. A., Giang, H. N., Bowman, E. D., Zhao, Y., Budhu, A., Schetter, A. J., Harris, C. C. 
(2009). MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the 
esophagus: Associations with survival. Clinical Cancer Research, 15(19), 6192–6200. 
http://doi.org/10.1158/1078-0432.CCR-09-1467 
Mathonnet, G., Fabian, M. R., Svitkin, Y. V, Parsyan, A., Huck, L., Pillai, R. S., Sonenberg, N. 
(2007). MicroRNA Inhibition of translation initiation in vitro by targeting the cap-binding 
complex eIF4F. Science, 317(5845):1764-7. 
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005). Passenger-Strand 
Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes. Cell, 
123(4):607-20. http://doi.org/10.1016/j.cell.2005.08.044 
McCrea, P. D., Turck, C. W., & Gumbiner, B. (1991). A Homolog of the armadillo Protein in 
Drosophila (Plakoglobin) Associated with E-Cadherin. Science, 254(5036):1359-61. 
Miller, J. R., & Moon, R. T. (1996). Signal transduction through beta-catenin and specification 
of cell fate during embryogenesis. Genes & Development, 10(20), 2527–2539. 
http://doi.org/10.1101/gad.10.20.2527 
Mohri, T., Nakajima, M., Takagi, S., Komagata, S., & Yokoi, T. (2009). MicroRNA regulates 
human vitamin D receptor. International Journal of Cancer, 125(6), 1328–1333. 
http://doi.org/10.1002/ijc.24459 
Mojarad, E. N., Kuppen, P. J. K., Aghdaei, H. A., & Zali, M. R. (2013). The CpG island 
methylator phenotype (CIMP) in colorectal cancer. Gastroenterology and Hepatology From Bed 
to Bench, 6(3):120-8. 
Molenaar, M., Wetering, M. Van De, Oosterwegel, M., Peterson-maduro, J., Godsave, S., 
Korinek, V., & Roose, J. (1996). XTcf-3 Transcription Factor Mediates β -Catenin-Induced 
Axis Formation in Xenopus Embryos. Cell, 86(3):391-9. 
Moser A, Mattes E, Dove W, Lindstrom M, Haag J, Gould M. (1993). ApcMin, a mutation in the 
murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. 
Proceedings of the National Academy of Sciences of the United States of America, 90(19):8977-
81.  
 
70 
 
Nagel, R., Le Sage, C., Diosdado, B., Van Der Waal, M., Oude Vrielink, J. A. F., Bolijn, A., 
Agami, R. (2008). Regulation of the adenomatous polyposis coli gene by the miR-135 family in 
colorectal cancer. Cancer Research, 68(14), 5795–5802. http://doi.org/10.1158/0008-5472.CAN-
08-0951 
Najdi, R., Holcombe, R., & Waterman, M. (2011). Wnt signaling and colon carcinogenesis: 
Beyond APC. Journal of Carcinogenesis, 10(1), 5. http://doi.org/10.4103/1477-3163.78111 
Nam, E. J., Yoon, H., Kim, S. W., Kim, H., Kim, Y. T., Kim, J. H., Kim, S. (2008). MicroRNA 
expression profiles in serous ovarian carcinoma. Clinical Cancer Research, 14(9), 2690–2695. 
http://doi.org/10.1158/1078-0432.CCR-07-1731 
Nguyen, T. A., Jo, M. H., Choi, Y.-G., Park, J., Kwon, S. C., Hohng, S., Woo, J.-S. (2015). 
Functional Anatomy of the Human Microprocessor. Cell, 161(6), 1374–1387. 
http://doi.org/10.1016/j.cell.2015.05.010 
Nichoalds, G. E. (1974) Assessment of status riboflavin nutriture by assay of erythrocyte 
glutathione reductase activity. Clinical Chemistry, 20(5), 624-628 
Nielsen, B. S., Jorgensen, S., Fog, J. U., Kilde, R., Christensen, I. J., Hansen, U., Nielsen, H. J. 
(2011). High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-
free survival in stage II colon cancer patients. Clinical and Experimental Metastasis, 28(1), 27–
38. http://doi.org/10.1007/s10585-010-9355-7 
Nishida, N., Mimori, K., Fabbri, M., Yokobori, T., Sudo, T., Tanaka, F., Mori, M. (2011). 
MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the 
proliferation of human gastric cancer cells in combination with trastuzumab. Clinical Cancer 
Research, 17(9), 2725–2733. http://doi.org/10.1158/1078-0432.CCR-10-2132 
Nishida, N., Nagahara, M., Sato, T., Mimori, K., Sudo, T., Tanaka, F., Mori, M. (2012). 
Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic 
miRNA clusters. Clinical Cancer Research, 18(11), 3054–3070. http://doi.org/10.1158/1078-
0432.CCR-11-1078 
Northcott, P. A., Fernandez-L, A., Hagan, J. P., Ellison, D. W., Grajkowska, W., Gillespie, Y., 
Taylor, M. D. (2009). The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven 
medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. 
Cancer Research, 69(8), 3249–3255. http://doi.org/10.1158/0008-5472.CAN-08-4710 
Nosho, K., Igarashi, H., Nojima, M., Ito, M., Maruyama, R., Yoshii, S., Shinomura, Y. (2014). 
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated 
pathway. Carcinogenesis, 35(4), 776–783. http://doi.org/10.1093/carcin/bgt374 
71 
 
Nottrott, S., Simard, M. J., & Richter, J. D. (2006). Human let-7a miRNA blocks protein 
production on actively translating polyribosomes. Nature Structural & Molecular Biology, 
13(12), 1108–15. http://doi.org/10.1038/nsmb1173 
Nusse, R. (2005). Wnt signaling in disease and in development. Cell Research, 15(1), 28–32. 
http://doi.org/10.1038/sj.cr.7290260 
Nusse R, Varmus H.E. Wnt genes. (1992). Cell, 69(7), 1073–87. 
Nusse, R., Varmus, H. E. (1982). Many Tumors Induced by the Mouse Mammary Tumor Virus 
Contain a Provirus Integrated in the Same Region of the Host Genome. Cell, 31(1):99-109. 
Nusslein-Volhard, C., & Wieschaus, E. (1980). Mutations affecting segment number and polarity 
in Drosophila. Nature, 287(5785), 795–801. 
O'Broin, S., and Kelleher, B. (1992) Microbiological assay on microtitre plates of folate in serum 
and red cells. Journal of Clinical Pathology, 45(4):344-7. 
O’Day, E., & Lal, A. (2010). MicroRNAs and their target gene networks in breast cancer. Breast 
Cancer Research : BCR, 12(2), 201. http://doi.org/10.1186/bcr2484 
Olive, V., Jiang, I., & He, L. (2010). Mir-17-92, a cluster of miRNAs in the midst of the cancer 
network. International Journal of Biochemistry and Cell Biology, 42(8), 1348–1354. 
http://doi.org/10.1016/j.biocel.2010.03.004 
Padi, S. K. R., Zhang, Q., Rustum, Y. M., Morrison, C., & Guo, B. (2013). MicroRNA-627 
Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human 
Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice. Gastroenterology, 145(2), 
437–446. http://doi.org/10.1053/j.gastro.2013.04.012 
Pal, S., Baiocchi, R. A., Byrd, J. C., Grever, M. R., Jacob, S. T., & Sif, S. (2007). Low levels of 
miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. 
The EMBO Journal, 26(15), 3558–69. http://doi.org/10.1038/sj.emboj.7601794 
Park, J.-E., Heo, I., Tian, Y., Simanshu, D. K., Chang, H., Jee, D., Kim, V. N. (2011). Dicer 
recognizes the 5’ end of RNA for efficient and accurate processing. Nature, 475(7355), 201–
205. http://doi.org/10.1038/nature10198 
Petersen, C. P., Bordeleau, M. E., Pelletier, J., & Sharp, P. A. (2006). Short RNAs repress 
translation after initiation in mammalian cells. Molecular Cell, 21(4), 533–542. 
http://doi.org/10.1016/j.molcel.2006.01.031 
 
72 
 
Pichiorri, F., Suh, S.-S., Ladetto, M., Kuehl, M., Palumbo, T., Drandi, D., Croce, C. M. (2008). 
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proceedings 
of the National Academy of Sciences of the United States of America, 105(35), 12885–90. 
http://doi.org/10.1073/pnas.0806202105 
Pizzini, S., Bisognin, A., Mandruzzato, S., Biasiolo, M., Facciolli, A., Perilli, L., Zanovello, P. 
(2013). Impact of microRNAs on regulatory networks and pathways in human colorectal 
carcinogenesis and development of metastasis. BMC Genomics, 14(1), 589. 
http://doi.org/10.1186/1471-2164-14-589 
Pogribny, I. P., Tryndyak, V. P., Ross, S. A., & Beland, F. A. (2008). Differential expression of 
microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats. Nutrition 
Reviews, 66(SUPPL.1), 64–66. http://doi.org/10.1111/j.1753-4887.2008.00064.x 
Power DG, Gloglowski E, Lipkin SM. (2010). Clinical genetics of hereditary colorectal cancer. 
Hematology/Oncology Clinics of North America, 24(5), 837-59. 
Pretlow, T. P., Edelmann, W., Kucherlapati, R., Pretlow, T. G., and Augenlicht, L. H. (2003). 
Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele. American Journal 
of Pathology, 163, 1757-1763 
Pufulete, M., Al-Ghnaniem, R., Leather, A. J. ., Appleby, P., Gout, S., Terry, C.,  Sanders, T. 
(2003). Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and 
cancer: a case control study. Gastroenterology, 124(5), 1240–1248. 
http://doi.org/10.1016/S0016-5085(03)00279-8 
Rao, T. P., & Kuhl, M. (2010). An updated overview on Wnt signaling pathways: a prelude for 
more. Circulation Research, 106(12), 1798–1806. 
http://doi.org/10.1161/CIRCRESAHA.110.219840 
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, E., Bettinger, J. C., Rougvie,  a E., Ruvkun, 
G. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis 
elegans. Nature, 403(6772), 901–906. http://doi.org/10.1038/35002607 
Reya, T., Duncan,  a W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Weissman, I. L. 
(2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 
423(6938), 409–414. http://doi.org/10.1038/nature01593 
Rijsewijk, F. (1987). The Drosophila Homolog of the Mouse Mammary Oncogene int-1 Is 
Identical to the Segment Polarity Gene wingless. Cell, 50(4), 649–657. 
 
 
73 
 
Ross, S., & Davis, C. (2011). MicroRNA, nutrition, and cancer prevention. Advances in 
Nutrition, 2(11), 472–485. http://doi.org/10.3945/an.111.001206.472 
Roy S, Levi E, Majumdar AP, Sarkar FH. (2012). Expression of miR-34 is lost in colon cancer 
which can be re-expressed by a novel agent CDF. Journal of Hematology and Oncology. 2012. 
5:58.  
Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., & Deng, G. (2011). Curcumin Modulates 
MicroRNA-203 – Mediated Regulation of the Src-Akt Axis in Bladder Cancer. Cancer 
Prevention Research, 4(10):1698-709. http://doi.org/10.1158/1940-6207.CAPR-11-0267 
Saydam, O., Shen, Y., Würdinger, T., Senol, O., Boke, E., James, M. F., Breakefield, X. O. 
(2009). Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-
cadherin and activating the Wnt/beta-catenin signaling pathway. Molecular and Cellular 
Biology, 29(21), 5923–40. http://doi.org/10.1128/MCB.00332-09 
Sayed, D., & Abdellatif, M. (2011). MicroRNAs in Development and Disease. Physiological 
Reviews, 91(3), 827–887. http://doi.org/10.1152/physrev.00006.2010 
Scapoli, L., Palmieri, A., Lo Muzio, L., Pezzetti, F., Rubini, C., Girardi, A., Carinci, F. (2010). 
MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. 
International Journal of Immunopathology and Pharmacology, 23(4), 1229–1234. 
Schee, K., Boye, K., Abrahamsen, T. W., Fodstad, Ø., & Flatmark, K. (2012). Clinical relevance 
of microRNA mir-21, mir-31, mir-92a, mir-101, mir-106a and mir-145 in colorectal cancer. 
BMC Cancer, 12, 505. http://doi.org/10.1186/1471-2407-12-505 
Schetter, A. J., Okayama, H., & Harris, C. C. (2012). Role of microRNA in colorectal cancer. 
Cancer Journal, 18(3), 244–252. http://doi.org/10.1097/PPO.0b013e318258b78f.The 
Seiden-Long, I., Navab, R., Shih, W., Li, M., Chow, J., Zhu, C. Q., Tsao, M. S. (2008). Gab1 but 
not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. 
Carcinogenesis, 29(3), 647–655. http://doi.org/10.1093/carcin/bgn009 
Selhub, J. (2002). Folate, vitamin B12 and vitamin B6 and one carbon metabolism. The Journal 
of Nutrition, Health & Aging, 6(1), 39–42. 
Semenov, M., Tamai, K., & He, X. (2005). SOST is a ligand for LRP5/LRP6 and a Wnt 
signaling inhibitor. The Journal of Biological Chemistry, 280(29), 26770–26775. 
http://doi.org/10.1074/jbc.M504308200 
Shen, K., Liang, Q., Xu, K., Cui, D., Jiang, L., Yin, P., Liu, J. (2012). MiR-139 inhibits invasion 
and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. 
Biochemical Pharmacology, 84(3), 320–330. http://doi.org/10.1016/j.bcp.2012.04.017 
74 
 
Siddiqui, I. A., Asim, M., Hafeez, B. B., Adhami, V. M., Tarapore, R. S., & Mukhtar, H. (2011). 
Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB 
Journal, 25(4), 1198–1207. http://doi.org/10.1096/fj.10-167924 
Siegel, R., Desantis, C., & Jemal, A. (2014). Colorectal Cancer Statistics, 2014. CA: Cancer 
Journal for Clinicians, 64(1), 104–17. http://doi.org/10.3322/caac.21220. 
Slaby, O., Svoboda, M., Michalek, J., & Vyzula, R. (2009). MicroRNAs in colorectal cancer: 
translation of molecular biology into clinical application. Molecular Cancer, 8(1), 102. 
http://doi.org/10.1186/1476-4598-8-102 
Song, J., Medline, A., Mason, J. B., Gallinger, S., and Kim, Y. I. (2000) Effects of dietary folate 
on intestinal tumorigenesis in the apcMin mouse. Cancer Research 60(19), 5434-5440 
Stamos, J. L., & Weis, W. I. (2013). The b -Catenin Destruction Complex. Cold Spring Harbor 
Perspectives in Biology, 5(1):a007898. 
Starlard-Davenport, A., Tryndyak, V., Kosyk, O., Ross, S. R., Rusyn, I., Beland, F. A., & 
Pogribny, I. P. (2010). Dietary methyl deficiency, microRNA expression and susceptibility to 
liver carcinogenesis. Personalized Nutrition: Translating Nutrigenetic/Nutrigenomic Research 
into Dietary Guidelines, 101, 123–130. http://doi.org/10.1159/000314517 
Stewart BW, Wild CP, editors (2014).World Cancer Report 2014. p16-27, Lyon, France: 
International Agency for Research on Cancer.   
Studzinski, G. P., Bhandal, A. K., & Brelvi, Z. S. (1985). Cell Cycle Sensitivity of HL-60 Cells 
to the Differentiation-inducing Effects of 1-alpha,25-dihydroxyvitamin D3. Cancer Research, 
45(8):3898-905. 
Sun, D., Yu, F., Ma, Y., Zhao, R., Chen, X., Zhu, J., Zhang, J. (2013). MicroRNA-31 activates 
the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by 
repressing RAS p21 GTPase activating protein 1 (RASA1). Journal of Biological Chemistry, 
288(13), 9508–9518. http://doi.org/10.1074/jbc.M112.367763 
Sun, M., Estrov, Z., Ji, Y., Coombes, K. R., & Harris, D. H. (2008). Curcumin 
(diferuloylmethane ) alters the expression profiles of microRNAs in human pancreatic cancer 
cells. Molecular Cancer Therapeutics, 7(3):464-73. http://doi.org/10.1158/1535-7163.MCT-07-
2272 
Suzuki, H., Takatsuka, S., Akashi, H., Yamamoto, E., Nojima, M., Maruyama, R., Toyota, M. 
(2011). Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of 
MicroRNA Genes in Colorectal Cancer. Cancer Research, 71(17), 5646–5658. 
http://doi.org/10.1158/0008-5472.CAN-11-1076 
75 
 
Tetsu, O., & McCormick, F. (1999). Beta-catenin regulates expression of cyclin D1 in colon 
carcinoma cells. Nature, 398(6726), 422–426. http://doi.org/10.1038/18884 
Tili, E., Michaille, J., Adair, B., Alder, H., Limagne, E., Taccioli, C., Croce, C. M. (2010). 
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting 
JunB and JunD. Carcinogenesis, 31(9):1561-6. http://doi.org/10.1093/carcin/bgq143 
Tong, Z., Liu, N., Lin, L., Guo, X., Yang, D., & Zhang, Q. (2015). miR-125a-5p inhibits cell 
proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. 
Biomedicine & Pharmacotherapy, 75, 129–136. http://doi.org/10.1016/j.biopha.2015.07.036 
Tryndyak, V. P., Ross, S. A., Beland, F. A., & Pogribny, I. P. (2009). Down-regulation of the 
microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced 
by a methyl-deficient diet. Molecular Carcinogenesis, 48(6), 479–487. 
http://doi.org/10.1002/mc.20484 
Tsang, W. P., & Kwok, T. T. (2010). Epigallocatechin gallate up-regulation of miR-16 and 
induction of apoptosis in human cancer cells. The Journal of Nutritional Biochemistry, 21(2), 
140–6. http://doi.org/10.1016/j.jnutbio.2008.12.003 
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Kuroda, M. (2011). miR-92 is 
a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Science, 102(12), 
2264–2271. http://doi.org/10.1111/j.1349-7006.2011.02081.x 
Ulrey, C. L., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2005). The impact of metabolism on 
DNA methylation. Human Molecular Genetics, 14(SPEC. ISS. 1), 139–147. 
http://doi.org/10.1093/hmg/ddi100 
Van de Wetering, M., Sancho, E., Verweij, C., De Lau, W., Oving, I., Hurlstone, A., … Clevers, 
H. (2002). The ??-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal 
cancer cells. Cell, 111(2), 241–250. http://doi.org/10.1016/S0092-8674(02)01014-0 
Van den Veyver, I. B. (2002). Genetic effects of methylation diets. Annual Review of Nutrition, 
22(1), 255–282. http://doi.org/10.1146/annurev.nutr.22.010402.102932 
Vlachos, I. S., Paraskevopoulou, M. D., Karagkouni, D., Georgakilas, G., Vergoulis, T., 
Kanellos, I., Hatzigeorgiou, G. (2015). DIANA-TarBase v7 . 0 : indexing more than half a 
million experimentally supported miRNA : mRNA interactions. Nucleic Acids Research, 
43(Database Issue), 153–159. http://doi.org/10.1093/nar/gku1215 
Volinia, S., Calin, G. a, Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Croce, C. M. (2006). A 
microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings 
of the National Academy of Sciences of the United States of America, 103(7), 2257–2261. 
http://doi.org/10.1073/pnas.0510565103 
76 
 
Wan, L., Zhu, L., Xu, J., Lu, B., Yang, Y., Liu, F., & Wang, Z. (2014). MicroRNA-409-3p 
functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met. Cellular 
Physiology and Biochemistry, 34(4), 1273–1290. http://doi.org/10.1159/000366337 
Wang, C. J., Zhou, Z. G., Wang, L., Yang, L., Zhou, B., Gu, J., Sun, X. F. (2009a). 
Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal 
cancer. Disease Markers, 26(1), 27–34. http://doi.org/10.3233/DMA-2009-0601 
Wang, G., Mao, W., Zheng, S., & Ye, J. (2009b). Epidermal growth factor receptor-regulated 
miR-125a-5p - A metastatic inhibitor of lung cancer. FEBS Journal, 276(19), 5571–5578. 
http://doi.org/10.1111/j.1742-4658.2009.07238.x 
Wang, G., Zhao, Y., & Zheng, Y. (2014a). miR-122 / Wnt / β -catenin regulatory circuitry 
sustains glioma progression. Tumour Biology, 35(9), 8565–8572. http://doi.org/10.1007/s13277-
014-2089-4 
Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R. J., Yu, J. (2009c). microRNA-21 
negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Research, 
69(20), 8157–65. http://doi.org/10.1158/0008-5472.CAN-09-1996 
Wang, S., Krinks, M., Lin, K., Luyten, F. P., & Moos, M. (1997). Frzb , a Secreted Protein 
Expressed in the Spemann Organizer , Binds and Inhibits Wnt-8. Cell, 88(6):757-66.  
Wang, X., Gocek, E., Liu, C.-G., & Studzinski, G. P. (2009d). MicroRNAs181 regulate the 
expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-
dihydroxyvitamin D3. Cell Cycle, 8(5), 736–741. http://doi.org/10.4161/cc.8.5.7870 
Wang, X., Lam, E. K. Y., Zhang, J., Jin, H., & Sung, J. J. Y. (2009e). MicroRNA-122a functions 
as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal 
cancers. Biochemical and Biophysical Research Communications, 387(2), 376–380. 
http://doi.org/10.1016/j.bbrc.2009.07.034 
Wang, Z., Sun, X., Wang, Y., Liu, X., Xuan, Y., & Hu, S. (2014b). Association between miR-
27a genetic variants and susceptibility to colorectal cancer. Tumor Biology, 35(3), 2151–2156. 
http://doi.org/10.1007/s13277-013-1285-y 
Welch, C., Chen, Y., & Stallings, R. L. (2007). MicroRNA-34a functions as a potential tumor 
suppressor by inducing apoptosis in neuroblastoma cells. Oncogene, 26(34):5017-22. 
http://doi.org/10.1038/sj.onc.1210293 
Willert, K., & Nusse, R. (2012). Wnt Proteins. Cold Spring Harbor Perspectives in Biology, 
4(9):a007864. 
Wodarz,  a, & Nusse, R. (1998). Mechanisms of Wnt signaling in development. Annual Review 
of Cell and Developmental Biology, 14, 59–88. 
77 
 
Wong, L. L., & Adler, P. (1993). Tissue Polarity Genes of Drosophila regulate the subcellular 
location for prehair initiation in pupal wing cells. Journal of Cell Biology, 123(1), 209–221. 
Xu, J., Zhu, X., Wu, L., Yang, R., Yang, Z., Wang, Q., & Wu, F. (2012). MicroRNA-122 
suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly 
targeting Wnt / b -catenin pathway. Liver International, 32(5):752-60.   
http://doi.org/10.1111/j.1478-3231.2011.02750.x 
Xu, R.-S., Wu, X.-D., Zhang, S.-Q., Li, C.-F., Yang, L., Li, D.-D., Zhang, B. (2013). The tumor 
suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. International 
Journal of Oncology, 42(2), 676–82. http://doi.org/10.3892/ijo.2012.1746 
Xu, X., Chen, H., Lin, Y., Hu, Z., Mao, Y., Wu, J., Xie, L. (2013). Microrna-409-3p inhibits 
migration and invasion of bladder cancer cells via targeting c-met. Molecules and Cells, 36(1), 
62–68. http://doi.org/10.1007/s10059-013-0044-7 
Yang, J., Cao, Y., & Sun, J. (2010). Curcumin reduces the expression of Bcl-2 by upregulating 
miR-15a and miR-16 in MCF-7 cells. Medical Oncology, 27(4):1114-8. 
http://doi.org/10.1007/s12032-009-9344-3 
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003). Exportin-5 mediates the nuclear export of 
pre-microRNAs and short hairpin RNAs. Genes & Development, 17(24):3011-6. 
http://doi.org/10.1101/gad.1158803.miRNA 
Yu, F., Deng, H., Yao, H., Liu, Q., Su, F., & Song, E. (2010). Mir-30 reduction maintains self-
renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene, 29(29), 4194–4204. 
http://doi.org/10.1038/onc.2010.167 
Yu, Y., Kanwar, S. S., Patel, B. B., Oh, P. S., Nautiyal, J., Sarkar, F. H., & Majumdar, A. P. N. 
(2012). MicroRNA-21 induces stemness by downregulating transforming growth factor beta 
receptor 2 (TGFβr2) in colon cancer cells. Carcinogenesis, 33(1), 68–76. 
http://doi.org/10.1093/carcin/bgr246 
Zekri, L., Huntzinger, E., Heimsta, S., & Izaurralde, E. (2009). The Silencing Domain of GW182 
Interacts with PABPC1 To Promote Translational Repression and Degradation of MicroRNA 
Targets and Is Required for Target Release. Molecular and Cellular Biology, 29(23), 6220–6231. 
http://doi.org/10.1128/MCB.01081-09 
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., He, X. (2005). A dual-kinase 
mechanism for Wnt co-receptor phosphorylation and activation. Nature, 438(7069), 873–877. 
http://doi.org/10.1038/nature04185 
 
78 
 
Zhang, J., Zhang, H., Liu, J., Tu, X., Zang, Y., Zhu, J., Zhang, J. (2012). MiR-30 inhibits TGF-β-
1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochemical 
and Biophysical Research Communications, 417(3), 1100–1105. 
http://doi.org/10.1016/j.bbrc.2011.12.121 
Zhang, J., Zhang, T., Ti, X., Shi, J., Wu, C., Ren, X., & Yin, H. (2010). Biochemical and 
Biophysical Research Communications Curcumin promotes apoptosis in A549 / DDP multidrug-
resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochemical 
and Biophysical Research Communications, 399(1), 1–6. 
http://doi.org/10.1016/j.bbrc.2010.07.013 
Zhang, J.-X., Song, W., Chen, Z.-H., Wei, J.-H., Liao, Y.-J., Lei, J., Luo, J.-H. (2013). 
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA 
expression analysis. The Lancet Oncology, 14(13), 1295–306. http://doi.org/10.1016/S1470-
2045(13)70491-1 
Zhong, H., Wang, H. R., Yang, S., Zhong, J. H., Wang, T., Wang, C., & Chen, F. Y. (2010). 
Targeting Smad4 links microRNA-146a to the TGF-β pathway during retinoid acid induction in 
acute promyelocytic leukemia cell line. International Journal of Hematology, 92(1), 129–135. 
http://doi.org/10.1007/s12185-010-0626-5 
Zhou, T., Zhang, G., Liu, Z., Xia, S., & Tian, H. (2013). Overexpression of miR-92a correlates 
with tumor metastasis and poor prognosis in patients with colorectal cancer. International 
Journal of Colorectal Disease, 28(1), 19–24. http://doi.org/10.1007/s00384-012-1528-1 
Zhu, W., Shiojima, I., Ito, Y., Li, Z., Ikeda, H., Yoshida, M., Op, C. O. S. (2008). IGFBP-4 is an 
inhibitor of canonical Wnt signaling required for cardiogenesis. Nature, 454(7202):345-9. 
http://doi.org/10.1038/nature07027 
Ziyan, W., Shuhua, Y., Xiufang, W., & Xiaoyun, L. (2011). MicroRNA-21 is involved in 
osteosarcoma cell invasion and migration. Medical Oncology, 28(4), 1469–1474. 
http://doi.org/10.1007/s12032-010-9563-7 
 
